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1 
INTRODUCTION 
Since Prasad et al. (I) reported zinc deficiency in 
Egypt and Iran, research interest in zinc metabolism and its 
functions in the body has increased. The biochemical functions 
in which zinc has been implicated as necessary include: 1) 
enzymes and enzymatic function, 2) protein synthesis, and, 
3) carbohydrate and lipid metabolism. 
Zinc deficiency has been shown to affect almost all 
stages of development from prenatal to adolescence (2, 3, 4) 
in all species studied. Important features of zinc deficiency 
include: 1) impaired food intake and growth retardation, 2) 
alopecia and gross skin lesions, 3) impaired wound healing, 
4) hypogonadism and suppression of the secondary sexual 
characteristics in males, 5) infertility, prolonged labor 
and parturition associated with excessive bleeding in the 
female, and, 6) congenital malformation of the fetus. Abnormal 
synthesis of nucleic acids seems to be the main mechanism 
underlying manifestations of zinc deficiency (5). 
Zinc is also necessary for normal cell-mediated and 
humoral immune responses. The weight of lymphoid organs 
(thymus, spleen and mesenteric lymph nodes) is reduced in 
zinc deficiency (6). Depressed vivo and in vitro immune 
responses have been shown in animals (6, 7, 8) and human 
beings (9, 10) in zinc deficiency compared to normal. Zinc 
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deficiency seems to affect cell-mediated immune response 
by the loss of the T-cell helper function. 
One of the biological functions of zinc which is of 
particular interest to this study is its role in lipid 
metabolism and prostaglandin (PG) synthesis. There are 
great similarities between essential fatty acid deficiency 
and zinc deficiency symptoms such as growth retardation and 
skin lesions. Bettger et al. (11) showed that zinc deficiency 
accentuated signs of EFA deficiency. They suggested that 
zinc is involved in the metabolism of arachidonic acid and 
therefore can affect PG metabolism. Manifestation of zinc 
deficiency in acrodermatitis enteropathica (AE, a heredity 
disease with faulty zinc absorption) has been attributed to 
its effect on PG synthesis (12). Abnormal metabolism of 
essential fatty acids has been reported in AE patients (13, 
14, 15). 
O'Dell et al. (16) demonstrated that the effects of zinc 
deficiency in pregnant rats were similar to the effects of 
toxic doses of aspirin which inhibit PG synthesis. Horrobin 
and Cunnane (17) showed that the symptoms of zinc deficiency 
can be partly treated by administration of evening primrose oil 
(72% linoleic acid, C18:2n-6, and 10% gamma-linolanic acid, 
C18:3n-6). They suggest that zinc seems to be essential 
for the conversion of linoleic acid to gamma-llnolenic acid. 
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and for the mobilization of dihomogammalinolenic acid (C20: 
3n-6) from membrane stores to form the one series of PG (see 
figure 1). 
With all the important roles of zinc in the biochemical 
functions of the body, very little is known about its absorp­
tion and the mechanism(s) involved in it. Different investi­
gators (18, 19, 20) have been able to separate a zinc binding 
ligand (ZBL) from the rat intestinal mucosa and contents. 
The exact nature of the ZBL is not clear, and indeed, the 
literature is very contradictory about this subject. PGE 
(20, 21, 22) has been implicated as a possible ligand and 
there is direct evidence for (20, 21, 22, 23) and against 
(24, 25, 26) it. There are however, indirect indications 
that PG might be involved in zinc homeostasis. Aspirin is 
one of the most generally used drugs in the therapy of 
rheumatoid arthritis (RA) and zinc level is altered in RA. 
patients (27, 28). In addition, aspirin is teratogenic in 
rats and Koshakji and Schulert (29) postulated that this 
teratogenic effect might be due to the insufficient avail­
ability of zinc to the fetus. 
If PG are involved in zinc metabolism modifying their 
level in different organs by changing their percursors in 
the diet or using an inhibitor of PG synthesis like aspirin 
and indomethacin should affect the zinc status of the rat. 
By the same token, if zinc is involved in PG synthesis 
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elimination of zinc from the diet should change the synthetic 
potential and/or existing level of PG in the tissues. 
The purpose of this study was to find: 1) what role, 
if any, PG might play in zinc absorption and biological func­
tions; this includes measuring food intake and weight gain, 
zinc concentration in different tissues, serum alkaline 
phosphatase activity (a zinc metalloenzyme), and the in 
vitro immune response to mitogens under conditions of altered 
zinc and PG status in rats. 2) What might be the effect of 
zinc deficiency on PG synthesis as measured by PG level in 
different tissues of rats. 
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REVIEW OF LITERATURE 
Biological Significance of Zinc 
The essentiality of zinc for microorganisms has been 
known for 100 years (30). Todd et al. (31) demonstrated in 
1934 that zinc was needed for normal growth in rats. Only 
in 1961, however, was it suspected that zinc deficiency 
occurred in human beings. Subsequently, the presence of zinc 
deficiency among Iranian and Egyptian villagers was discovered 
and the clinical symptoms were described (32). Since then 
research interest in zinc metabolism and its function in the 
body has increased. The biochemical functions in which zinc 
has been implicated as necessary include: 1) enzymes and 
enzymatic function, 2) protein synthesis, and 3) carbohydrate 
and lipid metabolism. 
Since the identification of zinc as an essential 
component of carbonic anhydrase (33), more than forty zinc 
metaUoenzymes have been recognized (34) . Those identified 
in mammalian tissues include alkaline phosphatase, carboxy-
peptidase and alcohol dehydrogenase. Important enzymes in 
metabolism of nucleic acids are zinc dependent, such as 
thymidine kinase and DNA and RNA polymerases. This critical 
role of zinc in nucleic acid metabolism and protein synthesis 
can explain the high requirement of zinc in young animals 
and its importance for normal growth and development. Zinc 
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deficiency is shown to affect almost all stages of development 
including prenatal (2), postnatal, infancy and childhood (3), 
and adolescence (4) in all species studied. 
Impaired food intake and growth retardation are promi­
nent features of zinc deficiency and those effects probably 
arise from impaired DNA synthesis and cell division. Nutri­
tional dwarfism and hypogonadism were the main clinical 
manifestations of zinc deficiency demonstrated in Iran and 
Egypt (4). The growth retardation effect of zinc deficiency 
is a combination of impaired appetite, food utilization, and 
normal taste sensation (hypogeusia). Hambidge et al. (35) 
discovered that poor growth and appetite, together with 
hypogeusia in young children in Denver, was associated with 
subnormal hair zinc level. Supplementation of children's 
diet with zinc corrected taste acuity, improved growth and 
increased hair zinc level. 
One of the features of zinc deficiency which is seen in 
all species is hair loss (alopecia) and gross skin lesions. 
Acrodermatitis enteropathica (AE), a heredity disease which 
appears in early infancy and is characterized by pustular 
and eczematoid skin lesions, alopecia, and diarrhea is due 
to impaired zinc absorption and responds to zinc therapy C36). 
The skin lesions and impaired wound healing in zinc deficiency 
are attributed to the involvement of zinc in RNA and DNA 
synthesis, incorporation of sulfur amino acids into skin 
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proteins, and collagen synthesis. Reduced collagen synthesis 
and alterations in collagen cross-linking in skin of' zinc 
deficient rats have been reported (37). 
Zinc is necessary for spermatogenesis and the development 
of the primary and secondary sex organs in the male, and for 
all phases of the reproductive process in the female from 
estrus to parturition and lactation. Atrophic seminiferous 
tubules were observed in the earliest study of the histo-
pathology of zinc deficiency in the rat (37). Hypogonadism, 
with suppression of the secondary sexual characteristics were 
among the first clinical features of zinc deficiency reported 
(1, 32). The effects of zinc deficiency in the female depend 
on the severity, timing, and duration of the deficiency. 
Hurley and Swenerton (38) showed that feeding a diet nearly 
free of zinc to female rats from weaning to maturity caused 
severe disruption of estrous cycles and in most cases no 
mating took place and the animals were infertile. When 
pregnancy occurred more than half of the implantation sites 
were resorbed. Surviving fetuses had less than half the 
normal body weight and nearly all showed gross congenital 
malformations which affected every organ system. The 
abnormalities seen were beyond that of food restriction. 
The effect of severe maternal zinc deficiency is very 
rapid. Hurley and Shrader (39) showed that after only 3 days 
of maternal deprivation of dietary zinc, abnormal development 
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was seen in preimplantation embryos. Gallaher and Hurley 
(40) in a recent publication demonstrated that the effect 
seen is a direct result of too little zinc for proper cell 
division and growth and not due to an indirect effect on 
maternal metabolism. In their study they demonstrated that 
zinc content of intrauterine fluid decreased significantly 
after four days of zinc deprivation. In addition to effects 
on the fetus, zinc deficiency has deleterious effects on 
mothers (41). Zinc deficiency during pregnancy caused 
difficulty of parturition, excessive bleeding and longer 
total time of delivery. The behavior of mothers after birth, 
was also different; for example, they did not consume the 
afterbirth and the offspring were randomly distributed about 
the cage. 
Zinc deficiency also impairs reproduction and normal 
development of the fetus in non-human primates (42) . The 
relationship between zinc deficiency and congenital mal» 
formation in human beings is not known. The only documented 
congenital deformation in humans related to zinc deficiency 
is that of Hambidge et al. (43) reporting an outcome of 
pregnancy of two AE patients. One of them gave birth to an 
achondroplastic dwarf, who died 1/2 hour after delivery. 
After the mother started therapy with diiodohyoxyquin 
(which increases zinc absorption), she gave birth to two 
normal children. Jameson (44) states that there is a strong 
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association between complications of pregnancy and low 
levels of zinc during the first trimester and there seems to 
be a higher incidence of congenital malformations in the 
infants of women with lower plasma zinc levels during pregnancy. 
One of the organ systems upon which zinc deficiency seems 
to have a detrimental effect is the central nervous system. 
Structural changes in the brain and organs associated with, 
the central nervous system of fetus and offspring due to 
maternal zinc deficiency are well-documented (45, 46). 
T^Jhether these structural changes have functional significance 
is not clear. Behavorial changes due to zinc deficiency has 
been reported however in rat and monkey (47). 
The main mechanism underlying manifestations of zinc 
deficiency during development seems to be abnormal synthesis 
of nucleic acid (,5). The impairment of nucleic acids causes 
alterations in differential rates of growth. These changes 
in normal growth rate lead to asynchrony in the development 
of tissues and organs (_5). Zinc also is needed for normal 
skeletal development (37), and might have a role in patho­
genesis of atherosclerosis. Recently it was shown C48) that 
zinc might be an important trace mineral in the process of 
post eruptive mineralization of the dental enamel and may 
reduce the susceptibility of teeth to caries. There is 
interesting evidence for involvement of zinc in some disease 
states like sickle cell anemia (49) and arthritis (50). Zinc 
is also necessary for normal cell-mediated and humoral immune 
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responses which will be discussed in more detail. 
Role of zinc in the immune system 
The recent interest in the effects of nutritional imbal­
ances on immunity functions has led to the study of immune 
responses in a variety of deprivation states including zinc 
deficiency. The first clue to the involvement of zinc in 
immune response came from the work of Miller et al.(51) in 1968. 
Their results indicated that zinc deficient animals had a 
reduced weight gain, anorexia, and other biochemical and 
physiological abnormalities. Of particular interest is their 
observation that thymus and spleen weight were markedly de­
pressed. In addition, peripheral lymphocyte counts and serum 
gamma globulin were reduced. Subsequently, decreased thymus 
weight and atrophy of thymic tissue were noted in rats (6) and 
mice (52). The study in mice is the first study that shows 
functional impairment of the immune system in zinc deficiency. 
In this study (52), it was shown that zinc deficient mice have 
depressed antibody response to keyhole limpet hemocyanin-p-
azophenylarsonate antigen. 
Subsequently other investigators have confirmed these 
results. Frost et al, (6) showed that in zinc deficient 
Blab/c mice the weights of lymphoid organs (thymus, spleen, 
and mesenteric lymph node) were far more depressed than those 
of non-lymphoid organs. They showed also that zinc deficient 
animals had altered response to sheep erythrocytes as measured 
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by hemolytic plaque-forming cells. The overall response to 
this antigen was depressed and delayed and it lasted longer 
than that of control animals. The authors have attributed 
the decrease in lymphoid organ weights and depressed antibody 
response to an impairment of DNA synthesis in zinc deficient 
animals. Both production of new lymphoid cells and active 
proliferation of resting antigen sensitive cells require a 
normal and constant DNA synthesis which is impaired in zinc 
deficiency. In order for the B-cell to respond to sheep 
erythrocytes it needs a T-cell to perform a "helper" function. 
Frost et al,(6) suggested that in the zinc deficient animal 
there is a loss of T-cell helper function. T-cells also 
control the duration of response and have a suppressive 
function over the B-cell response. These investigators, 
therefore, concluded that the impaired and longer lasting 
response to antigen in zinc deficient animals is due to loss 
of T-cell helper function. 
This conclusion was confirmed by other investigators (J) • 
DePasquale-Jardieu and Fraker (53) showed that a significant 
part of loss of T-cell helper function was due to zinc 
deficiency itself. Further suppression was produced, 
however, due to hyperactivity of the adrenal cortex and 
concomitant rise of glucocorticoids in zinc deficiency. 
Glucocorticoids have been shown (54) to cause functional 
alterations of the thymus. 
12 
Beach et al^ (55) studied the effect of postnatal zinc 
deficiency on the immune response of mice pups. They fed 
lactating mice from the day of parturition and their pups 
to 8 weeks of age, diets containing varying levels of zinc 
from 2.5 to 100 ppm. They observed severe growth retardation 
of lymphoid tissues, especially thymus. The magnitude of 
splenic and thymic hypogenesis was directly dependent upon the 
severity of the dietary zinc deficiency. There was also 
decreased splenic cellularity in the zinc deprived rats. 
Furthermore, at 4 weeks of age direct splenic plaque forming 
cell responses to sheep erythrocyte immunization were signif­
icantly diminished in severely and moderately zinc deprived 
rats during the postnatal period. In addition the serum 
immunoglobin profile of the zinc deficient mice was altered 
with decreased IgM, IgG and IgA. 
These findings have great implications in studying the 
prevalance of infection and immune deficiency among malnourished 
children. Low levels of plasma zinc commonly observed in 
children with moderate to severe protein energy malnutrition 
might be the cause of defective cell mediated immunity 
often seen in these children. Therapeutic administration 
of zinc might be beneficial to such patients. Zinc deficiency 
can also occur in patients with small bowl malabsorption 
syndrome and those receiving total parenteral nutrition. 
These patients have increased incidence of sepsis that 
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might be due to impaired cellular immunity caused by zinc 
deficiency. 
Abnormal cellular immune response is reported in AE 
patients (9). In infants with protein energy malnutrition 
and hypozincemia, it was found that atrophic thymus glands 
were restored to near normal with zinc therapy (56). Pekarek 
et al.(10) assessed the cellular immune response of a patient 
on total parenteral nutrition before and after zinc therapy. 
Blood analysis and anthropometric measurements indicated 
that the patient had low zinc and energy intake, but other 
nutrients such as vitamins A, B2, C and folate were normal. 
Cellular immunity was measured by delayed skin reactivity 
to dinitrochlorobenzene and by m vitro lymphocyte trans­
formation studies before and after zinc therapy. Both of 
these indices were abnormal before zinc therapy and returned 
to normal after 3 weeks of zinc therapy. Patients with 
Crohn's disease, who have low plasma zinc levels, demonstrated 
depression of T-lymphocytes (.57) . The above mentioned 
investigations suggest that adequate zinc nutriture is 
essential in humans just as it is in experimental animals 
for maintenance of certain aspects of cellular immunity. 
Because of the key role that zinc metalloenzymes play 
in RNA and DNA synthesis the effect of this trace element 
on cellular immunity might be due to its control over 
replication of cells involved in the immune response. Gross 
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et al.(8) tested this hypothesis in rats. They first 
demonstrated that zinc deficiency in rats depresses the 
blastogenic response of lymphocytes from thymus, spleen and 
peripheral blood to phytohemaglutinin (PHA) and conconavalin 
A (ConA) and pokeweed mitogen (PWM). PHA and ConA are 
primarily T-cell mitogens and PI'JM is both a T- and B-cell 
mitogen. In a subsequent study (58) they tested whether the 
depressed responses to PHA and ConA were due to impaired 
DNA and PvNA synthesis or due to the role that zinc plays as 
a functional component of plasma membrane.. Zinc supplementa­
tion has an inhibitory effect on many macrophage functions 
including mobility (59), phagocytosis, oxygen consumption, 
and bactericidal activity (60). Zinc plays an important 
role in the stabilization of plasma membrane. Zinc depri­
vation might result in membrane labilization with subsequent 
changes in membrane receptor-site availability and function. 
Chvapil et al. (60) showed that zinc-8-hydroxyquinolone 
which can not permeate the cell has a similar blastogenic 
effect to' zinc. Gross et al. (58) used Levamisole CL-2,3,5,6-
tetrahydrochloride-6-phenylimidazo (2,1-b) thiazole hydro­
chloride) to test the two possibilities. Levamisole improves 
reticuloendothelial cell function and phagocytosis and 
enhances responses to mitogens and antigens. They showed 
that addition of levamisole to cultures of zinc deprived 
spleen lymphocytes significantly improved their response to 
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PHA by 54%. The addition of levamisole to control lymphocyte 
cultures had no effect. Although levamisole's mode of action 
is not completely understood, it might promote the expression 
of T-cell receptors and inhibit the expression of Cg receptors 
on B cells . Because levamisole does not affect DNA or RNA 
synthesis and metabolism, and it corrects the depressed 
blastogenic response of lymphocytes in zinc deprived rats, 
the authors have suggested that "the immunodepression in 
zinc deficiency is a combined result of the biochemical lesion 
and membrane alterations, with the DNA synthetic defect not 
being rate limiting". 
The mechanism of zinc function in the immune system 
still remains unclear and needs further investigation. The 
above mentioned studies, however, elucidate the important 
role of zinc in the immune response and indicate that it can 
be used as a measurement of zinc status. Furthermore, in 
setting dietary requirements for zinc for animals and humans 
the total integrity of the immune system should be considered. 
Role of zinc in lipid metabolism and PG synthesis 
Zinc deficiency has been shown to cause changes in adipose 
tissue metabolism (61)• Some of the changes can be accounted 
for by different patterns of food intake between zinc 
deficient and pair fed control groups. Quaterman and Florence 
(62), however, noted that there was lower plasma insulin 
concentration after administration of a dose of glucose in 
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zinc deficient animals even beyond the differences caused by 
food intake pattern. Lower plasma insulin level was followed 
by a transient rise in plasma free fatty acid (FFA) concentra­
tion. The rise in FFA was attributed to an increased degrada­
tion of reserve triglyceride. 
Other investigators (63) also showed a rise in serum FFA 
in rats due to zinc deficiency. Sullivan et al. (64) recently 
reported that zinc deficiency enhanced lipid peroxidation in 
liver microsomes of rats. in that study, they compared the 
effect of zinc deficiency with that of ethanol on enhancement 
of lipid peroxidation. Cirrhotic patients have low seirum zinc 
levels (65) and chronic alcoholism is associated with liver 
cirrhosis, Sullivan et al.(64) fed groups of rats a control 
or a zinc deficient diet and half of each group received 3.85 
g/kg body weight (BW) of ethanol by stomach tube. Although they 
mentioned that there were pair fed groups for zinc deficient 
and ethanol fed groups, the results of the analysis for these 
groups were not shown. Their results showed that although 
zinc deficiency did not cause fatty liver as ethanol did, 
both groups had similar rises in hepatic phospholipids. 
Zinc deficiency and not alcohol caused an increase in 
diene conjugation of microsomal lipids which is used as an 
indicator of vivo lipid peroxidation. Both zinc deficient 
and ethanol fed groups showed increases in vitro enzymatic 
and non-enzymatic lipid peroxidation activity as measured 
by generation of malondialdehyde. They (64) have postulated that 
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the mechanism of increased lipid peroxidation in zinc deficien­
cy might be an increase in microsomal phospholipids leading 
to an increase in the level of unsaturated fatty acids. 
Increased unsaturated fatty acids can furnish more substrate 
for lipid peroxidation. Finally they have concluded that 
zinc deficiency might play a role in the development of 
alcoholic hepatitis. 
Chvapil et al. (66) showed that pharmacological doses 
of zinc (1000 ppm) decreased lipid peroxidation in whole 
liver homogenates and in the liver microsomal fraction, but 
not in other organs. This can be explained by the fact that 
excess zinc accumulates in liver but not in other organs. 
They also showed that the concentration of arachidonic acid 
(C20:4n-6) in the total fatty acids of the liver was signif­
icantly higher in rats fed a high zinc diet than a 
control diet and the concentration did not change after 60 
minutes incubation at 37°C. In addition, the magnitude of 
spontaneous hemolysis of erythrocytes was inhibited in rats 
fed 1000 ppm zinc in comparison with 40 ppm zinc. They have 
concluded, therefore, that dietary zinc controls lipid 
peroxidation in liver and red blood cells. The dietary level 
of zinc is about 30 ppm and although they mentioned that three 
groups of animals were fed 0.5 ppm, 40 ppm, and 1000 ppm 
zinc, they only showed the data for 40 ppm and 1000 ppm zinc. 
One can suspect that perhaps there was not a significant 
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difference between 0.5 ppm and 40 ppm zinc fed animals. 
Therefore, the physiological importance of their finding 
remains questionable. 
Koo and Turk (67) studied the effect of zinc deficiency 
on intestinal transport of triglyceride (TG) and showed that 
the rate of TG absorption decreased markedly in zinc deficient 
rats, although the digestion of TG was not affected by zinc 
deficiency. The only abnormality observed was in chylomicron 
formation which resulted in accumulation of fat droplets with­
in mucosa. This can be explained by impairment of protein 
synthesis in zinc deficiency. 
There are great similarities between essential fatty 
acid (EFA) deficiency and zinc deficiency symptoms. For 
example, both deficiencies are accompanied by growth retarda­
tion, parakeratosis, lengthened gestation period, parturition 
accompanied by excessive bleeding, and sterility of males. 
These resemblances have suggested that there might be a 
physiological interaction between the two. Bettger et al. (11) 
looked at these interactions in the rat. They fed rats diets 
containing low levels of zinc or EFA or both. A control group 
with adequate zinc and EFA and pair fed groups also were tested. 
They showed that low zinc status accentuated signs of EFA 
deficiency including dermal lesions and growth rate but had 
no effect on the fatty acid (FA) composition of plasma. 
Analysis of FA in dorsal foot skin of the rats, however, showed 
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that the severe zinc deficiency significantly affected the 
FA composition of skin from both the adequate and the low 
EFA groups. There was a two fold increase in percentage of 
arachidonic acid. They suggested that zinc is involved in 
the metabolism of arachidonic acid, perhaps by decreasing its 
catabolism. This could indicate a change in PG metabolism. It 
is worth pointing out here that Ziboh and Hsia (68) showed 
that external application of PGEn cured the dermal lesions 
of EFA deficiency. If zinc is essential for the conversion 
of arachidonic acid to PG, similar pathology should result 
from zinc deficiency, EFA deficiency or inhibition of PG 
synthesis. 
Later Bettger et al. (69). looked at interaction of zinc 
and polyunsaturated fatty acids (PUFA) in chicks. They did 
not find similar results. There was a negative correlation 
between PUFA and zinc deficiency and PUFA aggravated the 
signs of zinc deficiency. Although the authors stated that 
zinc deficiency caused an increase in arachidonic acid levels 
in dorsal foot skin of chicks, when the levels were compared 
to that of a pair fed control group, the result was not 
significant, i.e. the increase in C20:4n-6 is mainly due to 
food restriction. Although administration of indomethacin 
(an inhibitor of PG synthesis) improved the dermal lesions, 
topical application of PGEg and PGFg^ had no significant 
effect which is contrary to the results found by Ziboh and 
Hsia (68). The differences observed might be due to species 
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differences and different modes of PG metabolism and function. 
It has been suggested (12) that the manifestation of 
zinc deficiency in AE patients is due to its effect on PG 
synthesis. Abnormal metabolism of EFA is reported in AE 
patients (13, 14, 15). Patients with AE respond to zinc 
therapy or administration of penicillamine. Penicillamine 
was shown to increase PGE^ production (70). Clinical 
improvements may occur after supplementation of the diet 
with EFA even in the absence of zinc or diodoquin (13) which 
increases zinc absorption. This might indicate that at 
least part of the abnormalities in AE patients is due to 
altered EFA metabolism caused by zinc deficiency. 
Manku and Horrobin (71) showed that in an isolated per­
fused rat mesenteric preparation, zinc is a powerful stimulator 
of the production of a substance which has the characteristics 
of PGE^. They also postulated that zinc might be involved 
in the mobilization of dihomo-y-linolenic acid (.C20:3n-6) 
(72). Horrobin et al. (73) suggested that the function of 
zinc in treatment of acne is via stimulation of PG synthesis. 
O'Dell et al. (16) demonstrated that the effects of zinc 
deficiency on pregnant rats were similar to the effects of 
toxic doses of aspirin which inhibits PG synthesis. Both 
zinc deficiency and aspirin excess produced prolonged 
gestation, difficult parturition and lowering of blood 
pressure and body temperature. 
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Horrobin and Cunnane (17) proposed that zinc has two 
effects on EFA/PG metabolism. First, it seems to be essen­
tial for the activity of the delta-6-desaturase which converts 
linoleic acid to gamma-linolenic acid and, second, it seems 
to be required by the enzyme system which mobolizes C20:3n-6 
from membrane stores in order to form the one series of PG 
(see Figure 1). Their hypothesis is based on a series of 
experiments which will be summarized below. 
1) On the perfused mesenteric vascular bed of the rats, 
zinc stimulated PGE^ production within minutes (72); therefore, 
they suggest that the effect was not dependent on new enzyme 
synthesis. The effect could be blocked completely by 
aspirin-like drugs which block conversion of both C20;3n-6 
and C20:4n-6 to their respective PG. The effect could be 
imitated only by C20:3n-6 and PGE^ and not by arachidonic 
acid or by two series PG. The zinc effect could also be 
blocked by lithium. Lithium seems to block conversion 
of stored C20:3n-6 to free C20:3n-6 but not the conversion 
of C20:3n-6 to PGE^ (72). 
2) Male Wis tar rats were maintained on a zinc deficient 
diet for 5 weeks (74, 75) and compared with zinc deficient 
rats supplemented with a) evening primrose oil (EPO-72% 018: 
2n-6 and 10% C18:3n-6), b) safflower oil (SFO-83% C18:2n-6), 
and c) olive oil (OLO 10% C18:2n-6). The oils were injected 
subcutaneously at 250 yl/day. The severe growth retardation, 
hunched posture, keratosis, and alopecia of the zinc deficient 
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rats were not affected by OLO. SFO treated rats had improved 
growth and dermal condition. The growth improvements in EPO 
treated rats were three times those of SFO treated rats but 
dermal lesion improvement was similar. The EPO also increased 
organ weights (thymus, adrenal, and epididymal fat). The 
authors have attributed the difference seen to the presence 
of free C18:3n-6 in EPO and concluded that in zinc deficiency 
there is a block in C18:2n-6 desaturase which converts C18:2n-6 
to C18:3n-6 which after elongation to 20C can be used for PG 
synthesis. Since safflower oil affected the dermal lesions 
similarly to EPO they suggested that the effect of C18:2n-6 
in dermal lesions is not mainly via PG synthesis. 
3) The same experiment was repeated in male rats (17). 
SFO had no effect in reversing the effects of zinc deficiency 
on overall growth or on the weights of any organ, whereas 
primrose oil produced a substantial improvement toward 
normality. 
In summary, zinc seems to play regulatory roles in the 
metabolism of EFA and specifically in PG production. Zinc 
and EFA interaction may be of importance in a variety of 
clinical syndromes. 
Zinc Absorption and Metabolism 
In rats,zinc is mainly absorbed from the duodenum, ileum 
and jejunum. Homeostatic control of body zinc is partly 
regulated through zinc absorption (76). Zinc absorption is 
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affected by different factors including phytic acid, fiber, 
calcium, protein source and zinc itself (35). 
The mechanism of zinc absorption is not completely 
understood. Different hypotheses have been proposed with, 
scientific evidence for and against them. However, the 
general belief is that it is an active transport across the 
lumen and some sort of a ligand, the nature of which is very 
controversial, is involved. Suso and Edwards (77) were the 
first to propose that a low molecular weight zinc-binding 
ligand (LMî-J-ZBL) might be involved in transport of zinc. Hahan 
and Evans (18) separated a low molecular-weight ^^zinc-complex 
from the rat intestinal lumen and mucosa following oral 
administration of ^^Zn. Analysis of the ^^Zn-complex by 
thin layer chromatography (TLC) indicated that the complex 
had properties different from that of zinc salts and simple 
zinc-amino acid complexes. Subsequently Evans et al.(76) 
separated this ligand from pancreatic secretions of rat and 
dog and demonstrated that ^^Zn absorption was markedly 
diminished in rats in which the pancreatic duct was ligated. 
Furthermore, the uptake of ^^Zn by epithelial cells from 
everted intestinal segments was markedly increased in the 
presence of a ZBL fraction from pancreatic secretions. The 
authors suggested that a low molecular weight ZBL from the 
pancreas may facilitate zinc uptake into intestinal cells. 
It was also shovm that metal-free albumin might promote the 
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release of zinc from epithelial cells by interacting with 
zinc-binding sites on the basolateral plasma membrane. On 
the basis of these experiments Evans proposed a mechanism: 
"The pancreas secretes a ligand into the duodenum where zinc 
complexes with the molecule; complexed with the ligand, zinc 
is transported through the microvillus and into the epithelial 
cell where the metal is transferred to binding sites on the 
basolateral plasma membrane; metal-free albumin interacts 
with the plasma membrane and removes zinc from the receptor 
sites". 
Hurley et al. (19) reported the presence of a relatively 
low molecular weight ZBL in human milk which was not found in 
cow milk. The molecular weight was estimated by gel-filtration 
to be 8700. They suggested that this ZBL is responsible for 
the efficacy of human milk in treatment of patients with 
acrodermatitis enteropathica (children with AE will only 
develop signs of zinc deficiency if they are weaned from 
breast milk and fed cow milk). This LMW-ZBL was absent 
from the cow milk. They postulated that this ligand enhances 
the absorption of zinc in the normal neonate and that the 
beneficial properties of breast milk over cow milk for human 
neonates is due to the presence of this ligand. 
Duncan and Hurley (.78) subsequently separated the same 
ligand from rat milk. The interesting observation was that 
in new-born rats up to the age of 18 days, zinc was mostly 
associated with higher molecular weight ligand, but after 18 
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days zinc was associated mostly with a low molecular weight 
fraction. This suggested that the presence of a ZBL in rat 
milk prior to the development of the intestinal ZBL may 
enhance intestinal absorption of this nutrient during this 
period. 
The exact nature of the ZBL is very controversial. Song 
and Adham (20) purified the ZBLfrom rat intestine and demonstra­
ted that the ligand was similar to one of the prostaglandins. 
They then showed that PGEg facilitates both zinc absorption 
in vivo and zinc uptake into intestinal segments ^  vitro (23). 
In a subsequent study (22), they showed that addition of 200 y g 
PGE2 to the mucosal medium increased transport of ^^Zn 
across the everted jejunal sacs while decreased its 
transport. In contrast,addition of PGFg^ to the serosal 
medium increased the transport of ^^Zn from serosa to mucosa 
and PGE2 decreased it. Addition of 400 yg of PGE2 or PGF2g 
did not have an effect on histidine transport which was used 
as a control molecule. Oral administration of PGE2, with ^^Zn, 
three hours before the animals were sacrificed, caused an 
increase in zinc content of liver and pancreas. Further 
administration of 3 mg indomethacin orally, which amounts 
to almost 10 mg/kg BW and is a toxic dose, caused decreased 
liver zinc. They have concluded that PGEg and PGFg^ with 
their opposite effects on zinc absorption regulate transport 
of zinc across the intestinal mucosa. Whether the same 
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conclusion can be reached under physiological conditions is 
not clear. 
Sobocinski et al. (79) used doses of indomethacin between 
1 and 10 mg/100 gm/BW injected subcutaneously. They 
injected fed or fasted animals 17 hours before killing them. 
Zinc was measured in plasma and liver. Metallothionein was 
also quantitated in liver. The single injection of indo­
methacin in fed animals produced, by 24 hours, decreased 
plasma zinc, increased liver zinc, liver metallothionein, 
and gastrointestinal lesions. The same dose in 
fasted animals did not cause a significant change in zinc 
homeostasis. Indomethacin in fasted animals does not cause 
enteropathy. The authors concluded that in their study the 
effect of indomethacin on zinc homeostasis is associated with 
drug-induced enteropathy. In contrast to Song and Adham 
(22), these investigators showed that subcutaneous injection 
of 10 mg/100 gm/BW of indomethacin 16 hours prior to 
administration of an oral dose of ^^Zn increased zinc absorption. 
Song and Adham (22) used fasted animals and administered 
indomethacin orally whereas Sobocinski et al. (79) used fed 
animals and indomethacin was injected, which might explain the 
discrepancy seen between these two studies. 
Evans and Johnson (21) shov^ed that subcutaneous injection of 
aspirin reduced zinc absorption from bovine milk. These 
investigators have also demonstrated that ultraviolet spectral 
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characteristics of a purified fraction of ZBL from porcine 
duodenum is similar to PGE2. In addition, from labeled 
arachidonic acid given orally to rats appeared in the ZBL 
from intestine. 
The proposition that ZBL is a PG has been challenged by 
other investigators. Indeed, Evans and Johnson (21) who had 
originally suggested that ZBL is a PG later stated (80) that 
PGEg is not a biologically important ZBL and that they were 
misled because of the anomalous behavior of labile zinc 
complexes in solvent systems unbuffered with zinc ion. In 
their previous works they used classical gel-filtration 
chromatography. Apparently the dextran gel binds zinc and 
therefore cannot be used to detect labile zinc binding ligands 
in biological fluids unless it is preequilibrated with 
buffer containing zinc. Equilibration with buffer containing 
zinc also prevented dissociation of metal-ligand complex 
which would occur otherwise. 
Using the modified gel-filtration method Evans and 
Johnson (81) showed that the ligand is picolinic acid, a 
product of tryptophan metabolism. Subsequently, they fed 
rats diets containing 5% casein and 5% casein supplemented 
with either picolinic acid or tryptophan. Rats fed the low 
protein diet gained 170 ± 17 g in six weeks while rats fed 
the same diet supplemented with picolinic acid (0.2 mg per 
gram diet) gained 221 ± 8 g. The rats fed the unsupplemented 
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diet absorbed 133 ± 33 mg zinc per day while the supplemented 
rats absorbed 205 ± 26 mg zinc per day. The kidneys of the 
rats fed the supplemented diet had higher concentrations of 
zinc. The investigators further provided evidence that there 
was a linear relationship between the amount of pyridoxine 
HCl in the diet and the amount of zinc absorbed (82). Pyridoxal 
is needed as a cofactor in the pathway of tryptophan to 
picolinic acid. 
Robertson et al. (83) showed that metabolism of tryptophan 
was impaired in children who were affected with AE. Evans (84) 
demonstrated that human milk had a much higher concentration of 
picolinic acid than cow milk. Furthermore, pancreatic 
extract that is used under the trade name of Viokase was 
shown to have a therapeutic effect on AE patients (85). This 
pancreatic extract was shown to have a high concentration of 
picolinic acid. Based on the above observations, Evans (84) 
proposed a new hypothesis; "The production of picolinic acid 
from tryptophan and the secretion of this ligand into the 
intestinal lumen may be the rate limiting step in the 
absorption of dietary zinc." 
Interestingly, Lonnerdal et al. (24) at the same time 
proposed that the ZBL is citrate. They separated ZBL from 
human milk by means of gel-filtration, and ion-exchange 
chromatography. They treated their gels with sodium boro-
hydride to reduce charged groups and were able to recover 98% 
29 
of zinc from the column. They confirmed their results with 
infrared spectroscopy and nuclear magnetic resonance. These 
authors then concluded that the therapeutic value of human 
milk for AE patients is due to the greater content of bio-
available zinc-citrate in human milk than that of cow milk. 
They showed that zinc-picolinic acid complex in their system 
eluted at an entirely different position than did the ZBL of 
human milk. In addition, they were not able to find appreciable 
amounts of PGE2 in the ZBL. There are some unexplained points 
in this study; for example, the concentration of citrate in 
cow milk is higher than in human milk. Furthermore, there is 
no citrate in rat milk due to the activity of an ATP-citrate 
lyase in rat mammary tissue (86). In addition, Casey et al. 
(87) demonstrated that addition of citric acid or picolinic 
acid to the diet of children with AE did not change the 
uptake of zinc in these patients as measured by zinc tolerance 
tests. 
Cousins (88) disagrees in a number of points with, the 
above reported conclusions. He believes that liver plays a 
key role in zinc metabolism. Richards and Cousins (25) showed 
that changing dietary zinc causes changes in liver zinc associ­
ated with a higher molecular weight ligand (about 9000 Dalton) 
which was later characterized as metallothionein. They 
proposed that in liver the protein acted as a temporary 
storage form which is found in appreciable amounts during 
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short-term elevations of intrahepatocyte zinc. These investiga­
tors then showed that zinc-raetallothionein complex was also 
found in intestine. The amount of zinc associated with, the 
protein was dependent on the dietary zinc. T^Jhen protein 
synthesis was inhibited by use of actinomycin D, zinc accumu­
lated in mucosal cells and excess zinc did not influence 
absorption (.88). Smith et al. (.89) using isolated, vascularly 
perfused rat intestine concluded that LM1A7-ZBL was not required 
for zinc absorption. In their system SyM PGE2 decreased zinc 
absorption from lumen into the intestinal cells. Aspirin at 
150 mg/kg BW decreased transfer of infused ^^Zn to the vascular 
perfusate. At such a concentration of aspirin the effect 
might be due to other properties of aspirin than PG synthesis, 
especially since addition of PGE2 decreased absorption rather 
than increasing it. They have thus proposed that "zinc 
absorption is regulated, at least in part, by the amount of 
zinc that is bound to the inducible intestinal zinc binding 
protein." 
Subsequently, Cousins et al, (90) demonstrated that LMW-ZBL 
is actually a degradation product of metallothionein. They 
indicated that proteolysis is a major problem when working 
with preparations of intestinal cells. The zinc-protein com­
plex is also sensitive to temperature. These authors suggested 
that the intestinal LMW-ZBL as separated by gel filtration 
chromatography is a product of the method of isolation. 
However, they do not rule out the possibility that one or more 
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LMW-ZBL might play a role in zinc absorption. 
Panemangalore and Brady (91) also showed that zinc 
depletion decreased incorporation of sine into metallothionein. 
Ifhen the rats were replete with, zinc, the incorporation of 
the nutrient into metallothionein increased. Starcher et 
al.(92) also provided evidence that zinc absorption is directly 
proportional to intestinal metallothionein levels. In the 
sheep intestine, however, metallothionein was not responsive 
to dietary changes in zinc (93). Schricker and Forbes (26) 
showed that ZBL separated by them from intestinal mucosa using 
gel-chromatography behaved differently from PGE^-zinc complex. 
Their preliminary characterization of the ligand led them to 
believe that it is a small peptide. 
From the above described studies it is clear that the 
nature of ZBL is not unequivocally determined. In fact, the 
ZBL might actually be a heterogeneous group of compounds, 
each binding zinc under a particular set of conditions. Cousins 
et al. (90) demonstrated that when cytosolic zinc was increased 
by either oral administration of zinc or vitro addition 
2+ 
of Zn an appreciable amount of zinc was associated with LMW-
ZBL in contrast to the normal situation. Cousins and Smith 
showed (86) that in milk binding of zinc with low molecular 
weight ligand depends on zinc concentration. 
Although the mechanism proposed by Cousins indicates 
that metallothionein has an important regulatory effect on 
zinc homeostasis, it does not clarify how zinc passes across 
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the luman wall into the mucosa. Presence of another zinc 
binding ligand, the nature of which is not clear, might play 
an important role. 
As mentioned before, the role of PG in zinc absorption 
and/or metabolism is not clear yet. There are direct 
indications for (16, 20, 21, 22, 23) and against (24, 25, 26) 
it. There is, however, indirect evidence that indicates PG 
might be involved in zinc homeostasis. Aspirin is one of the 
most generally used drugs in the therapy of rhuematoid 
arthritis (RA) and zinc levels are altered in RA patients (94). 
Kennedy et al. (27) have demonstrated that plasma zinc 
concentrations in 47 males and 67 females with RA was lower 
than normal. Niedermeier and Griggs (28) also have shown that 
zinc sulphate therapy is beneficial in patients with RA. 
Koshakji and Schulert (29) showed that aspirin was teratogenic 
in rats. They postulated that this teratogenic effect might 
be due to the insufficient availability of Zn, Fe, and îfo 
to the fetus. Furthermore, Cunnane et al. (75) demonstrated 
that symptoms of zinc deficiency can be treated by administra­
tion of EFA which are precursors of PG synthesis. 
Although PG might not be structural components of ZBL, 
there are strong indications that they are involved in the 
regulation of zinc homeostasis. Further investigations 
considering the interaction of these physiologically important 
compounds with zinc metabolism is highly desirable. 
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Role of PG in Cell-mediated Immunity 
Prostaglandins are biologically active lipids synthesized 
from PUFA (figure 1) in the body and are found in almost all 
tissues. Since their discovery in the 1930s they have been 
implicated in the regulation of diverse biological functions 
such as adrenergic nerve transmission (95), blood pressure 
and blood flow (96), platelet aggregation (97), uterine and 
ovarian contraction (98), luteolysis (98), lipolytic processes 
(99), chronic inflammation (100), and cell-mediated immunity 
(101). Excellent reviews on the biological functions of 
PG are available (102, 103). 
One of the biological systems in which PG play an 
important regulatory role is the immune system. PG have been 
shovm to affect the secondary humoral and cell-mediated immune 
responses (104). The role of PG in chronic inflammation 
and the implication in the etiology of RA has been studied 
extensively (100). The function of PG in the immune system 
that is of interest to this study is its role in the control 
of cell-mediated immune response. 
PGE^ and PGE2 were first considered in cell-mediated 
immunity because of the earlier discovery that cyclic 
adenosine monophosphate (cAMP) might be a second messenger 
in the activation of lymphocytes. Parker et al. (105) showed 
that addition of PGE2 to human peripheral blood lymphocytes 
depressed cellular division induced by PHA, Stockman and 
Mumford (106) showed that addition of PGE^, PGE2, PGFgg and 
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PGAg decreased the blastogenic response of human peripheral 
blood lymphocyte to PHA (primarily a T-cell mitogen). The 
blastogenic response to ConA (both B-cell and T-cell mitogen) 
was hot as much affected. Furthermore the blastogenic response 
to PVJM (a B-cell mitogen) was not affected. The author, 
therefore, concluded that PG primarily exert their effect on 
T-cells. 
Schultz et al. (107) demonstrated that exogenously added 
PGE^ and PGE2, but not PGF2|^, inhibited the tumoricidal activity 
of interferon-activated macrophages of mice. Since the 
activated macrophage releases high concentrations of PGE2, 
the authors postulated that PGE2 could act locally in negative 
feedback inhibition to limit cell activities. Subsequently, 
it was shown that mitogen and antigen stimulated cultures of 
human and mouse lymphocytes released PG into the media. This 
was confirmed by Webb and Nowowiejski (108). 
Increase in PG synthesis due to antigen injection was 
also shown ^  vivo. Webb and Osheroff (109) showed that 
within 2 minutes following the intravenous injection of sheep 
blood cells (SRBC) there was a 20 to 80 fold increase in PGF2Q 
in the spleen. The authors pointed out that the increase of 
PGFgg is dependent upon thymus -derived T-cells, since no 
such increase was observed in athymic mice. Ferber et al. 
(110) reported that phospholipids of stimulated lymphocytes 
had higher ratios of polyenoic acids (CI 8;2 +C20:4) to saturated 
fatty acids. Zimecki and Webb (111) showed that indomethacin, 
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an inhibitor of PG synthesis, enhanced the vitro primary 
response to SRBC. Goodwin et al. (112) administered indo-
methacin to two patients with common variable immunodeficiency 
and measured the effect on depressed cellular immune response. 
They showed that the ^  vitro response of their lymphocytes 
to PHA increased during indomethacin treatment. In addition, 
after indomethacin injection the patients showed positive 
skin reactions to injected antigens. 
The reports of effects of EFA on the immune system are 
controversial and depend on whether an vivo or m vitro 
system is used (113). Dewille et al. (114) showed that EFA 
deficiency depressed humoral immunity in mice. An opposite 
effect of EFA was observed on cell-mediated immunity using 
in vitro binding of lymphocytes to SRBC (115). In addition, 
it is not clear whether the effect seen is due to a change in 
PG synthesis or is due to changes in membrane fluidity 
associated with EFA deficiency. 
The mechanism of PG function in cell-mediated immunity 
is not completely understood. Most investigators believe, 
however, that the endogenous synthesis of PG following antigen 
or mitogen stimulation is a negative regulatory signal for the 
lymphocyte. Webb et al. (101) proposed the hypothetical model 
for a role of PG in cell-mediated immunity (figure 2). In 
this model, PG are part of a feedback inhibitory loop that 
controls the magnitude of response to mitogenic or antigenic 
signals. The impairment of this regulatory function has been 
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suggested (.116) to play an important role in diseases with 
deficient T-cell function such as multiple sclerosis, Hodgkin's 
disease, Crohn's disease, and cardiomyopathy. 
PG 
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Cell Cell 
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Figure 2: Role of PG in control of cell-mediated immunity. 
(Reference 101) 
Conclusion 
With all the important roles of zinc in the biochemical 
functions of the body, very little is known about its absorp­
tion and metabolism. Different investigators (18, 77, 78) 
have been able to separate a zinc binding ligand from the rat 
intestinal mucosa and contents. The exact nature of the ZBL 
is not clear and indeed the literature is very contradictory 
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about this, subject. Pros, tag Ian din E has been implicated as a 
possible substance and there is some evidence in its support 
(20, 21, 23). There is also indirect evidence (27, 28, 29) 
that indicates PG might be involved in metabolism of zinc. 
On the other hand, zinc seems to be involved in synthesis 
and/or availability of precursors for biosynthesis of PG (17). 
There are great similarities between clinical features of zinc 
deficiency and EFA deficiency such as growth retardation, 
impairment of normal sex organ function, parakeratosis, etc. 
Acrodermatitis enteropathica, a hereditary disease with abnormal 
zinc absorption, can be treated with administration of zinc 
sulphate or EFA (13, 14). 
Furthermore, administration of toxic doses of aspirin, 
an inhibitor of PG synthesis, to pregnant rats resulted in 
clinical abnormalities similar to those of zinc deficiency (16). 
Although these studies strongly suggest that PG and zinc 
interact with each other in some point of their metabolism, 
it can not be accepted as a fact yet, the reason being mainly 
that most of these studies were carried out under unphysiologi-
cal conditions. In addition, both zinc and PG have such a 
wide variety of physiological functions that it is very hard to 
attribute an effect seen to a specific biological function. 
Nevertheless, because zinc and PG both play important roles in 
normal body functions any information about their interaction 
with each other can be very informative and interesting. 
38 
If PG are involved in zinc metabolism, modifying their 
level in different organs by changing their precursors in 
the diet or using an inhibitor of PG synthesis like aspirin 
or indomethacin should affect the zinc status. The correlation 
between dietary PUFA concentration and PG synthesis 
is documented (117, 118, 119) and aspirin and indomethacin 
are effective inhibitors of PG synthesis (120). By the same 
token, if zinc is involved in PG synthesis, elimination of 
zinc from the diet should change the synthetic potential 
and/or the existing level of PG in the tissues. 
The purpose of this study was to find: 1) what role, if 
any, PG might play in zinc absorption and biological function. 
This included measuring zinc concentration in different 
tissues, serum alkaline phosphatase activity (a zinc metallo-
enzyme), and ^  vitro immune response to mitogens; 2) what 
might be the effect of zinc deficiency on PG synthesis which 
includes measuring PG in different tissues. 
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METHODS AND MATERIALS 
The study included three experiments: 
Experiment I The purpose of this study was to 
determine the dose of aspirin or indomethacin which would 
inhibit prostaglandin (PG) synthesis, but would not have 
toxic effects. 
Experiment II This experiment was conducted to study 
the role of prostaglandins in zinc metabolism and the effect 
of zinc deficiency on PG synthesis. 
Experiment III This experiment was undertaken to 
study the effect of zinc deficiency and inhibition of PG 
synthesis on the blastogenic response of peripheral blood 
lymphocytes to PHA and ConA. 
Animals and Care 
In all the studies, weanling male rats of Wistar strain 
born and raised in the stock colony of the Iowa State Univer­
sity Food and Nutrition Laboratory were used. The rats were 
individually caged in stainless steel cages and maintained 
at 22°C and 45-55% relative humidity. Acid washed glass food 
jars and polyethylene bottles with polyethylene stoppers 
also were used. The animals were randomly assigned to the 
experimental diets, which were provided fresh twice weekly. 
Diets and deionized water were provided ad libitum unless 
otherwise specified. All the utensils used in providing the 
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diets were either stainless steel or acid washed. The animals 
were weighed weekly. 
Experiment I 
In this experiment 18 weanling male rats were randomly 
assigned to one of the following groups. 
Group A - was fed the control diet with the composition 
shown in Table 1. This diet is adequate in zinc and meets 
the requirement of rats according to the National Academy of 
Sciences (121). It is similar in gross composition to the 
average diet consumed in the U.S. 
Group B - was fed the control diet with 50 mg/kg body 
weight (BW)/day of aspirin (2-hydroxybenzoic acid acetate 2-
carboxyphenyl ester) mixed with the diet weekly. 
Group C - was fed the control diet but received 50 mg/ 
kg BW/day of aspirin (Sigma Company, St. Louis, MO) intra-
peritoneally (IP), Aspirin was dissolved in sterile physi­
ological saline. 
Group D - was fed the control diet with 2.5 mg/kg BW/ 
day of indomethacin (l-[P-chlorobenzoyl]-5-methoxy-2-methyl 
indole-3-acetic acid) (Sigma Company, St. Louis, MO), in the 
diet. 
Group E - was fed the control diet with 5 mg/kg BW/day 
of indomethacin in the diet. 
Group F - was fed the control diet but received 1 mg/kg 
BW/day of indomethacin IP, Indomethacin was dissolved in 
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Table 1: Composition of diets 
Ingredient % Weight 
Egg white^ 19.0 
DL-Methionine^ 0.4 
Corn starch^ 25.3 
Sucrose^ 25.2 
Cellulose^ 2.5 
Zinc free salt mix*^'® 4.5 
Vitamin mix^ 2.0 
Fat (combination of beef tallow® and safflower 
oil" or safflower oil) 21.2 
Total 100.0 
^United States biochemical, Cleveland, Ohio. 
^Argo brand from Iowa State University food service. 
^lowa State University food service. 
^According to National Academy of Sciences (121); made with 
analytical grade reagents. For all except zinc deficient 
group zinc was added. Amount in 100 kg diet: Ca, 300 gm; 
chlorine, 60 gm; sodium, 251 gm; phosphorus 500 gm; 
selenium, 10 mg; potassium, 900 gm; iodine, 100 mg; 
manganese, 7 gm; magnesium, 30 gm; iron, 5 gm, chromium, 
0.5 gm; copper, 1.5 gm; zinc, 3 gm. 
®Salts used were; CaCOo, 1500 gm; NaCl, 98.80 gm; KOHPOA,  
2004 gm; Na2HP04, 654.5 gm; MhSOA^HoO, 21.60 gm; MgO, 
99.60 gm; FeSO^.THoO, 24,90 gm; CrClg.&HoO, 2,2 gm; CUSO4. 
5H2O, 5.90 gm; ZnSOA.HoO, 13.20 gm; Na^SeO., 20,90 mg ; 
KI, 131.0 mg. 
^Amount in 100 kg diet: vitamin A acetate, 400,000 lU; 
vitamin Do, 40,000 lU; Dl-ct tocopherol acetate, 20,000 
lU; menadione, 100 mg; vitamin B]_2, 10 mg ; biotin, 50 mg ; 
folic acid, 200 mg; thiamin HCl, 500 mg; para-amino-
benzoic acid, 20 g ; ca pantothenate, 2 g ; niacin, 3 g ; 
pyrodoxin HCl, 1 g ; riboflavin, 1 g; choline chloride, 
400 g; ascorbic acid, 10 g ; com starch to 2 kg. 
^Carriage House, Meat and Provisions Company, Ames, Iowa. 
^Vegetable Oil Company, Richman, CA. 
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sterile 1 M phosphate buffer, pH 8. The animals were fed 
the experimental diets for 15 days. 
Animals were weighed weekly and food intake was recorded. 
Necropsy and sample collection 
On the day of necropsy, food jars were taken out at 6 A. 
M. and returned to the cages at 8 A.M. to synchronize eating. 
The animals were anesthetized with ether and the following 
samples were collected. 
1) Blood was collected from the exposed jugular vein. 
It was incubated for 10 minutes at 37°C in a shaking water 
bath. After exactly 10 minutes 0.1 ml/ml of whole blood of 
4.2 mM aspirin in 0.1 M potassium phosphate buffer (KPi), 
pH 7.4, was added to the blood. The serum was removed and 
immediately frozen and kept at -20°C for analysis of PG. 
2) Approximately 0.5 gm liver samples were homogenized 
on ice with a polytron homogenizer with 10 volumes of 0.1 M 
KPi for 2 minutes. The homogenates were then incubated at 
37°C in a shaking water bath for 10 minutes. PG synthesis 
was stopped by addition of 0.5 volumes of 42 mM aspirin in 
0.1 M KPi, pH 7.4. The samples were then frozen immediately. 
Another 0.5 gm sample from each liver was homogenized 
in 10 volumes of 42 mM aspirin in 0.1 M KPi solution for 2 
minutes. These samples were also frozen for PG analysis. 
Experiment II 
Seventy weanling male rats weighing about 50 gm were 
randomly assigned to the following groups : 
Group A - was fed the control diet with the composition 
' sho^vn in Table 1. All the control diets were supplemented 
with 30 ppm zinc, added to the salt mix. Fat in the control 
diet was composed of 20% beef tallow and 1.2% safflower oil. 
Group B - was fed a high polyunsaturated fatty acid 
(PUFA) diet. This diet was similar to the control diet ex­
cept that 21.2% fat was provided from safflower oil. 
Group G - was fed the control diet plus 2 mg/kg BW/day 
of indomethacin (this dose was selected based on the results 
of Experiment I). 
Group D - was pair fed to Group C with the control diet. 
Group E - was fed the control diet plus 50 mg/kg BW/day 
of aspirin. In order to get a homogeneous distribution of 
drugs in the diet, the drug dilution method was used (which 
involved mixing drug with a very small amount of diet and in­
creasing the diet gradually). The drugs were added to the 
diets weekly and the amount added was increased with increase 
of body weight and food intake. 
Group F - was fed a zinc deficient diet which was the 
control diet except that no zinc was added to the salt mix 
and extreme care was taken to avoid any zinc contamination 
(see animals and care). The analysis of the diet using a 
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dry ashing method (122) showed that the diet had less than 
1 ppm zinc. 
Group G - was pair fed to Group F with the control diet. 
Food intakes of Group C and Group F were recorded. 
daily considering their waste. The average consumed by these 
groups was fed to their corresponding pair fed groups. The 
animals were maintained on the diets for 30 days. 
Necropsy and sample collection 
All animals were fasted four hours prior to anesthesia, 
then were anesthetized with ether. Stainless steel surgery 
equipment was used for all the biopsies. 
The following samples were collected: 
A. Blood was collected from the exposed jugular 
vein in 10 ml polyethylene disposable syringes with stainless 
steel needles for the following samples. 
1. 2 ml for PG analysis. This sample was 
processed as explained above. 
2. 2 ml was delivered to acid washed poly­
ethylene tubes which contained 2 drops of heparin (Sigma 
Company, St. Louis, MO)(1000 U/ml deionized water of Na 
heparin). The blood was then centrifuged at 909 X g for 
10 minutes. Plasma was separated and frozen for zinc analysis. 
3. About 2 ml of blood was used to obtain serum 
for alkaline phosphatase measurement. 
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B. Thymus was taken out and weighed. 
C. Lung - two samples were taken from the lung. 
1. Approximately 0.5 gm sample was weighed and 
homogenized with 10 volumes of 42 mM aspirin solution in 0.1 
M KPi, pH 7.4. Komogenization was done on ice with a poly-
tron homogenizer. Care was taken that all the samples were 
handled in exactly the same way. This sample was frozen on 
dry ice and saved for PG analysis. 
2. Approximately 0.5 gm lung was weighed and 
homogenized with 10 volumes of 0.1 M KPi, pH 7.4 on ice. 
The homogenate was then incubated for 10 minutes in a 37°C 
shaking waterbath. After 10 minutes the PG synthesis was 
stopped by addition of 0,5 volume of 42 mM aspirin solution 
in 0.1 M KPi buffer. This sample was frozen on dry ice and 
saved for PG analysis, 
3. The rest of the lung was weighed and kept 
in polyethylene plastic bags for zinc analysis. 
D. Liver - two samples were taken for PG analysis. 
The procedure and handling of samples were similar to that 
of the lung samples. The rest of the liver was also weighed 
and saved for zinc analysis. 
E. The small intestine was excised from pylorus 
to cecum. The intestine was cleansed of excess blood 
with tissue. It was then cut into segments and the 
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contents flushed with a 0.85% NaCl solution. The volume was 
recorded. Zinc contamination was avoided by using deionized 
water in preparation of saline and wearing polyethylene 
gloves. The following samples were taken from the contents: 
1, 2 ml was delivered to small tubes which con­
tained 1 ml of 42 mM aspirin in 0.1 N KPi buffer for PG 
analysis. 
2. 2 ml was delivered to acid washed polyethylene 
containers for zinc analysis. 
F. Mucosa - pieces of intestine were then cut open and 
mucosa was scraped off with acid washed glass slides and 
weighed. The total mucosal collection was then homogenized 
in 10 volume of 0,1 M KPi buffer on ice, Two ml of homo-
genate was incubated for 10 minutes in a 37°C shaking water-
bath. At 10 minutes PG synthesis was stopped by addition 
of 1 ml of 42 mM aspirin in 0.1 M KPi buffer. One ml of 
homogenate was removed to an acid washed polyethylene con­
tainer for zinc analysis before addition of aspirin. 
All the samples were immediately frozen on dry ice and 
kept at -20°C for the appropriate analysis. 
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Experiment III 
Twenty-four weanling male rats were randomly assigned 
to the following groups : 
Group A - was fed the control diet. 
Group B - was fed the high polyunsaturated fat diet. 
Group G - was fed the control diet plus 2 mg/kg BW/day 
of indomethacin. 
Group D - was fed the zinc deficient diet. 
The composition of the diets was similar to that of 
Experiment II. 
The animals were maintained on the diets for 30 days. 
Food intakes and weight gains were recorded. 
Necropsy and sample collection 
After four hours fasting the animals were anesthetized 
with ether, and blood was collected from the exposed jugular 
vein. A 2 ml sample was processed for PC analysis as ex­
plained before and 5 ml was delivered to a centrifuge tube 
containing 10 U/ml heparin (1000 U/ml Na heparin in water) 
under sterile conditions for a lymphocyte stimulation assay. 
Analytical Methods 
Prostaglandin analysis 
Prostaglandins F2^, E^, E2, 6 keto PGF^^ (PGI2), throm­
boxane B2, and 13, 14, dihydro 15 keto prostaglandin ¥2^ were 
measured by radioimmunoassay as described by Hwang et al. 
(117) and McCosh et al. (1923). The method involved an 
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overnight precipitation of each PG specific antiserum 
with anti-rabbit gamma globulin. The PGE^ antiserum 
had a cross reactivity of 15% with PGE2 and the PGEg anti­
serum had a cross reactivity of 19% with PGE^. The other PG 
antisera did not show cross reactivity with each other. 
Parallelism of each PG in each tissue was checked. Standards 
were a gift from the Upjohn Company (Kalamazoo, MI). Tritiated 
PGE^, E2, TXBg, and PGF2Q were purchased from New England 
Nuclear (Boston, MA.) and tritiated 13,14 dihydro 15 keto-
PGF2g and 6 keto PGF^^ were purchased from Amersham (Arling­
ton Heights, XL). 
Zinc analysis 
Plasma was diluted 1 to 4 with deionized water and the 
diluted samples were directly analyzed with a Unicam SP 90 
atomic absorption spectrometer and used in accordance with 
the manufacturer's operating manual. The wave length was 
set at 214 nm, the most sensitive absorption line for zinc. 
The air flow was 6 1/min and that of propane was 0.5 1/min. 
All the tissue samples were digested in nitric acid 
using the method discussed by Slavin et al. (124). Standards 
were prepared by diluting stock atomic absorption zinc 
reference solution (Fisher Scientific Company, Fairlawn, NJ) 
in nitric acid and deionized water so that the standards and 
samples had similar water to nitric acid ratios. For plasma 
standards were diluted with deionized water only (125). 
49 
Alkaline phosphatase 
Serum alkaline phosphatase activity was measured using 
a Sigma kit (kit number 104LL). The 15 minute incubation 
method was used and the direction in the accompanying manual 
(126) was followed. 
Lymphocyte stimulation with PHA and ConA 
The method developed by Jackson and Laird (personal 
communication, National Animal Disease Laboratory, Ames, lA) 
was used. Heparinized blood was centrifuged at 315 X g for 
40 minutes. The buffy coat was collected in 10 ml pipets 
and suspended in approximately 10 ml Ca and Mg free Dulbecco 
medium (phosphate buffered saline solution, pH 7.2 made at 
the National Animal Disease Laboratory, Ames, lA) with 
heparin (.10 U/ml).. 
The suspension was centrifuged for 40 minutes at 815 X g. 
Contaminating red blood cells were lysed with ammonium 
chloride in 0.05 M tris buffer pH 7.2 with 10 U/ml heparin 
C8.3 gm ammonium chloride/11. Cells were then washed with 
medium containing heparin. The composition of the medium 
was as below; 
Values given for 100 ml of medium. RPMI 1640 (Grand 
Island Biological Co,, Grand Island, NY)_ ; 30 mM HEPES buffer 
(Sigma Co. , St. Louis, MO)., 1..2 ml; 30 mM NaHCOg (Mallinckrodt, 
St, Louis, MO), 4 ml; 1.6 mM L-glutamine (Grand Island Bio­
logical Co., Grand Island, NY), 0.8 ml; sterile water, 85 ml; 
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penicillin potassium G (Pfizer, New York, NY), 100 U; strep­
tomycin sulfate (Pfizer, New York, NY), 10 mg; gentocin 
(Sobering, Kenilworth, NJ), 15 mg. 
After centrifugation the cells were resuspended in the 
medium at a concentration of 4 x 10^ cell/ml. Viability of 
the cell suspension was determined using the trypan blue 
exclusion method (.127) and exceeded 90%. The procedure 
usually yields about 70% lymphocytes. The stimulants, PHA 
and ConA, affect T-cell lymphocytes specifically. The rela­
tive number of cells as possibly affected by treatment is 
corrected for by use of the stimulation index which is a 
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ratio of stimulated to nonstimulated H-thymidine incorpora­
tion . 
Two T-cell mitogens, PHA and ConA, were used. PHA and 
ConA dilutions were prepared in medium with 10% heat inacti­
vated fetal calf serum (prepared at National Animal Disease 
Laboratory, Ames, lAi, PHA (Burroughs-Wellcome, Greensburg, 
NC) and ConA (Calbiochemicals, San Diego, CA) were used in 
0.5 and 1 yg per well concentrations. Mitogens were added 
to each well in 100 yl volumes. All concentrations were 
tested in triplicate. Control cultures containing unstimu­
lated lymphocytes were also tested in triplicate. 
Cultures were then incubated for 72 hours at 37°C in a 
humidified atmosphere of air with 5% COg. At this time 1 yCi 
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of H-thymidine (New England Nuclear, Boston, MA; Specific 
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activity 6.7 Ci/mmol) in 22 jjl of medium was added to each 
well. The cultures were returned to incubators for 12 hours. 
The cells were then harvested with a micro-automated sample 
harvester (Otto Hiller Co., Madison, WI) onto a glass-fiber 
filter (0.5 x 8 inches) (Whatman, Inc., Clifton, NJ). Cell 
samples were placed in polyethylene miniscintillation vials 
(Isolab, Akron, OH). Four milliliters of scintillation 
fluid (Scintiverse, Fisher Scientific Co., Fairlawn,NJ) was 
added. The vials were counted in a Packard Tri-Carb C2425 
liquid scintillation counter (Downers Grove, IL). Results 
were obtained as mean CPM, which were used to calculate the 
mean stimulation index (SI) for each mitogen concentration. 
The SI is the ratio of the mean CPM of stimulated cultures 
to those of unstimulated cultures. 
Statistical analysis 
Results of Experiment II were analyzed by analysis of 
variance (128) and means were compared by use of Duncan's 
multiple range test at a 5% level of probability (129). 
Group means are reported with pooled standard error of the 
means. Data in Experiment I and III were analyzed by Stu­
dent's t-test. In addition, the results of Experiment II 
were also analyzed by Student's t-test. There was no dif­
ference between the results obtained by these two different 
statistical procedures unless otherwise mentioned. 
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RESULTS 
Experiment I 
This experiment was designed to determine a non-toxic 
dose of aspirin and indomethacin that would inhibit PG pro­
duction. Rats in Group F (receiving 1 mg/kg BW/day of 
indomethacin by injection) died after 2 injections. The 
only pathological sign seen at autopsy was local tissue reac­
tion at the injection site. The phosphate buffer which was 
used to dissolve indomethacin had a pH of 8 which could have 
been the cause of the local reaction. This pH was recom­
mended by the researchers at the Merck Company (personal 
communication, Merck & Co. Inc., Rahway, NJ) to make the 
indomethacin soluble in the buffer. According to the corres­
pondent at the Merck Company, they had used this method be­
fore with success. Rats in Group E (receiving 5 mg/kg BW/ 
day indomethacin in the diet)_ died after 8 days with peri­
tonitis which is one of the predominant signs of indomethacin 
toxicity.. Group B (receiving 50 mg/kg BW/day of aspirin in 
the diet)., and Group C (receiving 50 mg/kg BW/day aspirin 
intraperitoneallyl had food intakes and weight gains similar 
to those of the control group (Table 2). The weight gains 
and food intakes of the rats in Group D (receiving 2.5 mg/kg 
BW/day of indomethacin in the diet) were slightly lower than 
those of the control group. 
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Table 2. The effect of prostaglandin synthesis inhibitors 
on weight gain and food intake of rats, (mean ± 
standard error of the mean, n=3) 
Treatment Weight gain Food intake 
gm gm 
Control 62.00 ± 5.55 11.00 ± 0.25 
Aspirin 
(50 mg/kg BW/day IP) 60.00 ± 0.01 9.50 ± 0.55 
Aspirin 
(50 mg/kg BW/day PO) 62.00 ± 2.53 11.00 ± 0.15 
Indomethacin 
(2.5 mg/kg BW/day PO) 49.00 ± 3.54 9.30 ± 0.71 
PGF2g was measured in the serum samples and the results 
indicated that all the treatments used (aspirin, injected or 
used in the diet, and indomethacin in the diet) caused 
inhibition of PGF2g production by more than 50%. Based on 
the above results it was decided that 50 mg/kg BW/day of 
aspirin and 2 mg/kg BW/day of indomethacin in the diet are 
safe and effective doses. These doses inhibit PG production 
but do not interfere with the normal growth of the animals. 
In addition, they can be given in the diet the same as the 
other treatments. Therefore, those doses were used in 
Experiment II. 
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Experiment II 
The purpose of this experiment was to study the effect 
of changing PG level vivo on the zinc status of the rats 
and the effect of zinc deficiency on PG production. Table 
3 shows the average food intakes and weight gains of the 
animals receiving different treatments. 
Table 3: The effect of zinc deficiency and prostaglandin 
modifiers on food intake and weight gain of the 
rats (means with the same letter are not signif­
icantly different. n=10 per treatment). 
Treatment Food intake Weight gain 
gm gm 
Control 12 .40^ 161 . 90*' 
PUFA^ 12 . 8 0 *  179 .30* 
Indo.2 11 . 50* 170 .00*'^ 
Asp, ^ 12 .10* 156 .90^ 
-Zinc 6 .60^ 59 .70^ 
-Zinc PF^ 88 . 9 0 °  
Pooled SEM^ 0 .65 6 .58 
^Polyunsaturated fatty acid diet. 
2 2mg/kg BW/day indomethacin in the diet. 
3 50 mg/kg BW/day aspirin in the diet. 
'^Pair fed to zinc deficient rats with control diet. 
^Standard error of the mean. 
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As can be seen in Table 3, aspirin, indomethacin and PUFA fed 
groups had similar food intakes and weight gains to those of 
the control group. Food intake and weight gain were reduced 
significantly in the zinc deficient group as expected. The 
zinc deficient pair fed group had reduced weight gain but not 
as much as the zinc deficient group. There were no differ­
ences in food intake and weight gain of the indomethacin pair 
fed group from those of the control or the indomethacin fed 
group and preliminary analyses of PG and zinc in their serum 
revealed that they were not different from the control group. 
Therefore, no further analyses were performed on this group. 
Table 4; The effect of zinc deficiency and prostaglandin 
modifiers on organ weights of the rats (means with 
the same letter are not significantly different) 
(n=10 per treatment). 
Treatment gut mucosa liver lung tibia thymus^ 
gm 
Control 3. 10^ 9. 20^ 1. 20^ 0. 33^ 0. 39^ 
PUFA 2. y O^.C 10. 30^ 1. 40^ 0. 35^ 
Indo. 2. 6 o^.b,c 10. 20^ 1. 40^ 0. 34^ 0. 46^ 
Asp. 2. y o^.b 9. 20^ 1. 20^ 0. 32^ 0. 35^ 
-Zinc 1. 90^ 4. 00^ 0. 67^ 0. 22^ 0. 16^ 
-Zinc PF 2. 20^'C 4. 90^ 0. 75^ 0. 27^ 
Pooled SEM 0. 23 0. 38 0. 01 0. 02 0. 05 
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Table 4 shows the organ weights of animals with different 
treatments. Both food restriction and zinc deficiency caused 
decreased weight of all organs studied. Organ weights of 
PUFA, indomethacin and aspirin treated animals were the same 
as those of controls. Although the organ weights of the zinc 
deficient animals were slightly lower than their pair fed 
group, the difference is not statistically significant. When 
the ratio of organ weight to the body weight was compared (Table 
5) the zinc deficient group had a significantly higher organ 
weight ratio than other groups in all organs studied except 
for the thymus. There was no difference between the thymus 
weight to body weight ratio of zinc deficient animals and that 
of the control group. 
Table 5: Effect of zinc deficiency and prostaglandin modifiers 
on the organ weight to body weight ratio of the rats 
(means with the same letter are not significantly 
different) (n=10 per treatment) 
Treatment gut mucosa liver lung tibia thymus 
Control 0. 019b.c 0 .057^ 0. 008^ 0. 0021^ 0. 0025* 
PUFA 0. OI5C 0 .059^ 0. 008^ 0. 0019^ 
Indo. 0. 016^ 0 .059b 0. 008^ 0. 0020^ 0. 0026* 
Asp. 0. Olgc 0 .059b 0. 008^ 0. 0022^ 0. 0020* 
-Zinc 0. 035* 0 .071^ 0. 012* 0. 0040* 0. 0025* 
-Zinc PF 0. 026^ 0 .056% 0. 009b 0. 0032* 
Pooled SEM 0. 002 0 .004 0. 001 0. 0003 0. 0004 
^n=6 per treatment. 
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As far .as the general appearance of the animals, where the 
zinc deficient animals were less active than controls and 
had hair loss, the indomethacin and aspirin fed group were 
healthy and normal and no difference could be detected between 
them and the control group. The same was true for the PUFA 
treatment. 
Table 6 shows the zinc concentration in different organs. 
The zinc concentration was significantly lower in the plasma, 
gut contents and tibia of the zinc deficient group than those 
of the control and the zinc deficient pair fed groups. Zinc 
deficiency, indomethacin and aspirin treatments decreased 
the zinc concentration in the mucosa, and PUFA diet increased 
it, but the difference was not statistically significant 
(control, 32.50; PUFA, 39.80; indomethacin, 26.90; aspirin, 
27.40; zinc deficient, 18.70). Aspirin, indomethacin, and 
PUFA treatments did not change the zinc concentration in any 
other organ tested. Zinc concentrations in lung and liver 
were not affected by the treatments. 
Table 7 shows the results of alkaline phosphatase activity 
in the serum. The student's t-test was used for analysis of 
this parameter. Zinc deficiency decreased serum alkaline 
phosphatase activity significantly (P<0.05). Other treat­
ments did not have any effect on the activity of this 
enzyme. 
Prostaglandins F2^, E2, , 6 keto F^^ and 13,14dihydro-
15 keto prostaglandin Fg^ (met Fg^) were measured in serum, 
Table 6: The effect of zinc deficiency and prostaglandin modifiers on zinc 
concentrations in plasma, gut contents, gut mucosa, liver, lung, 
and tibia of rats (means with the same letter are not significantly 
different) (n=10 per treatment) 
Treatment Plasma 
Gut 
content 
Gut 
mucosa Liver Lung Tibia 
yg/ml y g / g m  y g / g m  y g / g m  y g / g m  
Control 1 . 4 0 ^ ' ^  4 5 . 5 0 ^  3 2  5 o a , b  2 9 . 0 0 *  1 6 . 8 0 ^ ' ^  1 5 0 . 3 0 *  
PUFA 1 . 1 0 ^  5 0 . 8 0 ^  3 9 . 8 0 *  3 0 . 6 0 *  2 0 . 8 0 * ' ^  1 5 3 . 0 0 *  
Indo. 1 . 2 0 * ' b  4 9 . 3 0 *  2 6 . 9 0 * ' ^  2 9 . 7 0 *  1 7 . 4 0 ^ ' ^  1 6 0 . 8 0 *  
Asp. 1 . 5 0 &  4 9 . 8 0 *  2 7 . 4 0 * ' b  2 8 . 6 0 *  1 6 . 4 0 ^  1 7 7 . 1 0 *  
-Zinc 0 . 5 0 ^  6 . 8 0 ^  1 8 . 7 0 ^  2 5 . 7 0 *  1 9 . 6 0 * ' b ' C  3 9 . 8 0 ^  
-Zinc PF 1 . 3 0 * ' b  5 0 . 2 0 *  3 1 . 3 0 * ' ^  3 2 . 5 0 *  2 1 . 7 0 *  1 6 1 . 1 0 *  
Pooled SEM 0 . 0 9  1 0 . 1 0  5 . 0 0  2 . 3 0  7 . 2 0  9 . 8 0  
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gut contents and mucosa, liver and lung. Thromboxane was 
also measured in serum and lung. Tables 8-14 show the PG 
levels in the different organs measured. 
Table 7; The effect of zinc deficiency and prostaglandin 
modifiers on serum alkaline phosphatase activity 
of the rats (n=10 per treatment) 
Treatment Alkaline phosphatase^ 
Sigma unit/ml 
Control 9.79 ± 1.11 
PUFA 6,83 ± 0.65 
Indo. 7.89 ± 0.76 
Asp. 11.19 ± 1.52 
-Zinc 3.66 ± 0.33-
-Zinc PF 7.46 ± 1.07 
^Mean ± standard error. 
2 Significantly different from the control, P<0.05. 
In serum, indomethacin and aspirin treatments inhibited 
synthesis of all PG tested more than 50% and almost 9-0% in the 
case of PGE21 PGFgg, and TXB2. Production of met was 
also inhibited significantly by indomethacin (Table 8). Zinc 
deficiency decreased PGEg (19.40 ng/ml for the control rats 
and 12.30 ng/ml for the zinc deficient rats) and PGFg^ (8.80 
60 
ng/inl for the control rat and 6.40 ng/ml for the zinc defi­
cient rats) production slightly but the difference did not 
reach statistical significance. 
Table 8: The effect of zinc deficiency and prostaglandin 
modifiers on concentration of different PG in 
the serum after 10 minutes incubation at 370C in 
rats (means with the same letter are not statis­
tically different) (n=10 per treatment). 
Treatment PGEi PGE« PGFg Met Fr, TxB^ L A Lo. Za Z 
ng/ml 
Control 3. 20* 19. 40* 8. r80* 0, 19b, c 78, ,10 
PUFA 3. 40* 14. ,30^'C 6. , 50^'^^ 0. ,28^ 76. ,37 
Indo. 1. 50^'C 1. ,70^ 1. ,70^'^ 0. 09^ 11, ,42 
Asp. 1. 00^ 0. ,90^ 1. ,00^ 0. IS^'d 3, ,71 
-Zinc 2. 60*'b 12. 30*'^ 6. 40*'^ 0. ,40* 70. ,60 
-Zinc PF 3. 20* 17. , 70^ 7. 00^'^ 0. ,20^ 119. ,22 
Pooled SEM 0. 47 4. 62 1. ,60 0. ,03 20. 76 
The interesting observation was that zinc deficiency signif­
icantly increased production of met F2^- No increase in PG 
production was observed by increasing the PUFA content of 
the diet. 
In the gut contents indomethacin and aspirin inhibited 
PGE2 and PGI2 synthesis (Table 9). The inhibition was not 
statistically significant for PGE^, PGF2^, and met F2^. 
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Table 9: The effect of zinc deficiency and prostaglandin' 
modifiers on the total amount of different PG 
in the gut contents of rats (means with the same 
letter are not significantly different)(n=10 per 
treatment) 
Treatment PGE^ PGE2 ^2a PGIg 
ng 
Control 10. 77a,b 63, , 3 8 *  115, ,16& 4. 5 4 *  52. 0
 
0
 
PUFA 15. 33^ 41. , 4 4 b  109, . 6 2 *  7, 11^ 35. 00 
In do. 9. 00*'b 41. , 60^ 96, ,62*'b 4, , 7 5 *  17. 14 
Asp, 8. 88a,b 27, ,50^ 103, ,OO^'b 3. , 8 4 *  14. 2 8  
-Zinc 4. 00^ 26, ,44b 63, ,00^ 2. , 7 3 *  10. 22 
-Zinc PF 6. 70^ 29, , 2 5 b  93, ,16*'b 3. 15* 23. 00 
Pooled SEM 2. 14 4, , 8 9  12, .18 0, ,81 4. 94 
Zinc deficiency decreased PGE^, PGE2. PGF2^, and PGI2 produc­
tion. Food restriction (zinc deficient pair fed group) also 
decreased the concentration of the above mentioned PG, however, 
zinc deficiency seemed to have a greater effect than food 
restriction alone on PGF2g and PGI2 levels. The effect of 
PUFA on PG production was not statistically significant. There 
was a positive correlation between PGE^ and zinc concentration 
in the gut content (correlation coefficient 0.35, P<0.01). 
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In gut mucosa, the effect of none of the treatments 
reached statistical significance, except for the inhibition 
of met F2^ production by indomethacin (Table 10). This is 
partly due to the large standard error. The variability 
among the samples within a treatment seen in mucosa might 
be due to the fact that PG production is very sensitive to 
trauma, and it is very hard to standardize trauma to the 
tissue during scraping of the gut to obtain mucosa. 
In the liver samples, homogenized in 42 mM aspirin as 
rapidly as possible, indomethacin and aspirin treatments 
decreased PG synthesis. Zinc deficiency and food restric­
tion both decreased synthesis of met significantly 
but food restriction was more effective than zinc defi­
ciency. Synthesis of other PG were depressed but the dif­
ferences did not reach statistical significance. Animals 
on high PUFA diet had lower levels of PGE2 and met ¥2^ than 
controls. The m vitro production of PG was similarly af­
fected, i.e., indomethacin and aspirin inhibited PG syn­
thesis in liver homogenates incubated for 10 minutes prior 
to addition of aspirin. Zinc deficiency and food restric­
tion also decreased PG synthesis, but the depression was 
only significant for PGE^. Zinc deficiency itself, how­
ever, decreased formation of F2^ significantly. 
Table 10: The effect of zinc deficiency and prostaglandin modifiers on the 
concentration of different PG in the gut mucosa of rats after 10 
minutes incubation at 37°C (means with the same letter are not 
significantly different) (n=10 per treatment) 
Treatment PGE-, PGE^ PGF„ Met F„ PGI„ 1 z la la 1 
ng/gm 
Control 27. lia.b 346. 63^ 626. 90*'^ 39 .42*'b 133. 7ia,b 
PUFA 18. 00^ 236. 22^ 579. ,60*'b 40 93a,b 133. SO^.b 
Indo. 21. 60^ 186. 90^ 595. ,00*'^ 12 .02^ 77. 30^ 
Asp. 18. 60^ 230. 44^ 464. ,13^ 21 03b. c 65. 83^ 
-Zinc 29. 60*'b 351. 00^ 889. 33* 31 .69^'^ 166. 30* 
-Zinc PF 36. 90^ 274. 80* 885, .88* 63 .44* 164. 30* 
Pooled SEM 4. 07 65. 59 109 .57 8 .39 29. 35 
Table 11: The effect of zinc deficiency and prostaglandin modifiers on the 
concentration of different PG in rat liver samples homogenized in 
42 mM aspirin immediately (means with the same letter are not 
significantly different) (n=10 per treatment) 
Treatment PGE^ PCE? PGF2^ Met PGI2 
ng/gm 
Control 3 8 . 7 8 *  94.22* 130 .11* 10.06* 18.00*'b 
PUFÂ 51.10* 19.63b 58 .57* 3 . 5 3 b  27.78* 
Indo. 37.50* 45.89*'^ 33 .78* 1.93b 8.33^'^ 
Asp. 22.11* 11.56^ 38 .38* 2 . 8 3 b  4.11^ 
-Zinc 22.44* 11.60^ 79 .78* 3.12^ 12.22^'^ 
-Zinc PF 21.30* 7.90^ 39 .38* 2.81^ e.Gjb'C 
Pooled SEM 9.87 19.77 32 .10 2.11 4.04 
Table 12; The effect of zinc deficiency and prostaglandin modifiers on the 
concentration of different PG in rat liver homogenates after 10 
minutes of incubation at 37°C (means with the same letter are not 
significantly different) (n=10 per treatment) 
Treatment PGE^ PGEg PGFg^ Met ^ 2^ PGIg 
ng/gm 
Control 222. 89^ 953 .44*'% 726. lia.b.c 59 .87* 166.22* 
PUFA 243. 78^ 1188 .90* 861. 10* 20 .75%'= 139.20* 
Indo. 94. 33^ 3 74 .60^ 386. 00^ 15 .61= 103.80* 
Asp. 120. 38^ 698 .43%'= 496. 75b, c 23 .38%'= 104.25* 
-Zinc 129. 50^ 677 llb.c 694. 33* » b,c 16 .56= 156.50* 
-Zinc PF 116. 70^ 549 llb.c 747. 10*'% 42 .90*'% 155.40* 
Pooled SEM 31. 76 140 .59 108. 88 7 .63 28.17 
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In vivo synthesis of PG in the lung was inhibited by 
aspirin and indomethacin (Table 13). Both inhibitors were 
more effective in inhibiting PGE2 synthesis than other PG. 
Zinc deficiency and food restriction both decreased syn­
thesis of PGEg significantly. PGE^ synthesis was also re­
duced but did not reach statistical significance. Although 
not statistically significant, zinc deficiency seemed to 
be more effective in decreasing synthesis of PGE^ than 
food restriction alone (7.86 ng/gm vs 13.56 ng/gm). Food 
restriction on the other hand was more effective in reduc­
ing met F2^ production than zinc deficiency. PUFA in­
creased synthesis of PGI2 significnatly. The vitro 
synthesis of PG in the 10 minute incubation homogenates 
was inhibited by indomethacin and aspirin (Table 14). 
Aspirin was a more potent inhibitor here. Zinc deficiency 
increased production of met F2^ significantly. 
In summary, indomethacin and aspirin inhibited PG 
production in all organs tested. The degree of inhibition 
at the dose used was slightly different among different 
PG and the organs tested. Production of met Fg^ was also 
inhibited in most organs studied. PUFA increased synthesis 
of met F2^ in the gut contents, and that of PGI2 in the lung 
samples homogenized in aspirin immediately. Zinc deficiency 
Table 13; The effect of zinc deficiency and prostaglandin modifiers on the 
concentration of different PG in rat lung samples homogenized 
in 42 mM aspirin immediately (means with same letter are not 
significantly different) (n=10 per treatment) 
Treatment PGE^ PGEg PGFg^ Met PGIg 
ng/gm 
Control 2 5 .  4 3 a .b 1 5 2 .  5 0 &  4 3  . 5 0 *  3 . 5 3 *  
CM 
7 0 ^  
PUFA 4 4 .  5 0 &  6 1 .  0 0 ^  3 9  . 5 0 *  2 . 0 0 * ' ^  5 9 .  7 8 *  
Indo. 1 6 .  O O & ' b  2 4 .  8 6 ^  3 9  .  7 8 *  2 . 3 2 * ' b  1 4 .  4 4 ^  
Asp. 1 7 .  2 3 3 ,b 2 3 .  
0
 
0
 2 3  . 0 0 *  1 . 0 0 ^  1 2 .  0 0 ^  
-Zinc 7 .  00
 
4 6 .  8 0 ^  2 4  . 1 4 *  2 . 5 4 ^ ' ^  2 2 .  3 3 ^  
-Zinc PF 1 3 .  5 6 ^  4 9 .  4 4 ^  2 0  . 0 0 *  1 . 5 8 ^  5 .  94b 
Pooled S EM 8 .  6 0  9 .  6 2  7  . 1 6  0 . 4 9  5 .  9 4  
Table 14: The effect of zinc deficiency and prostaglandin modifiers on the 
concentration of different PG in rat lung homogenates after 10 
minutes incubation at 37°C (means with the same letter are not 
significantly different) (n=lO per treatment) 
Treatment PGE , PGE-, PGF„ Met F„ PGI« 1 L 2a 2a 2 
ng/gm 
Control 215. 75*'b 709, .OO^'b 748. 79* 10. ,93b 5852. 70* 
PUFA 213. 50&'b 973, 30& 751, ,13* 16. 34*.b 4959, ,30* 
Indo. 107. 88^ 570, .56^'^ 354, ,78^ 5. 91^ 3575. 80^ 
Asp. 88. 89^ 369, .25% 345. 25^ 6. 95b 206. 11^ 
-Zinc 229, 80* 918, .90* 628, .90* 22. ,38* 5770, ,50* 
-Zinc PF 166. 90^ 959 .90* 533, .88*'^ 14. 36*'b 5634. ,00* 
Pooled SEM 17. ,71 93 .02 85, .73 3, .48 386. ,37 
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and food restriction significantly decreased PGEg synthesis, 
in gut contents, and liver and lung samples homogenized 
in aspirin immediately, PGE^ synthesis in incubated liver 
homogenate, PGF2g and PGIg synthesis in gut content, and met 
^2a Pz^duction in liver homogenates. The synthesis of other 
PG in the different organs was also decreased but the 
differences did not reach statistical significance. Zinc 
deficiency significantly decreased synthesis of PGFg^ and 
in the gut contents more than food restriction. Zinc 
deficiency also increased production of met F2^ in serum, 
and lung homogenates incubated for 10 minutes. In addition, 
in the gut contents, there was a positive correlation 
between zinc and PGE^ concentrations. 
Experiment III 
The purpose of this study was to investigate the effect 
of zinc deficiency and change in PG level on the blastogenic 
response of peripheral blood lymphocytes to T-cell mitogens 
(PKA and ConA). The data in this experiment were analyzed 
by the Student's t-test and results are reported as mean ± 
standard error of the mean. 
Zinc deficient amimals had decreased food intake and 
weight gain (Table 16) when compared to the control animals. 
The other treatments did not affect food intake or weight 
gain. 
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Table 15: The effect of zinc deficiency and PG modifiers 
on food intake and weight gain of rats (mean 
± SEM, n=6 per treatment) 
Treatment Food intake Weight gain 
gm 
Control 14. ,23 + 1, ,46 187. 33 ± 13, .75 
PUFA 
CO 1—1 
20 ± 0, ,58 217. 00 ± 13, .75 
Indo. 13. 62 ± 0. ,42 206. 17 ± 15, ,42 
-Zinc 10. 00 + 1, ,66^ 99. 17 f 17, 
I—1 o
 
m
 
^Significantly different from the control at P<0.05. 
Table 16 shows the serum PGE^ and plasma zinc concentra­
tion. As in Experiment II, zinc deficiency decreased plasma 
zinc concentration and the other treatments did not have any 
effect. Indomethacin decreased PGE^ level significantly. 
The experimental conditions of Experiments II and III were 
similar and the results of food intake, weight gain, plasma 
zinc and serum PGE^ in Experiment III agree with those of 
Experiment II. Therefore, it is assumed that the other 
parameters that were not measured in Experiment III behaved 
similarly to those of Experiment II. 
Table 17 shows the blastogenic response of peripheral 
blood to two different concentrations of PHA and 
ConA, Zinc deficiency decreased the stimulation index (SI, 
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Table 16. The effect of zinc deficiency and PG modifiers 
on plasma zinc and serum PGE]_ concentrations of 
rats (mean ± SEM, n=6 per treatment) 
Treatment Zinc PGE^ 
(yg/ml) (ng/ml) 
Control 1.89 ± 0.10 3.18 ± 0.95 
PUFA 1.43 ± 0.06 2.23 ± 0.33 
Indo. 1.63 ± 0.42 1.60 ± O.25I 
-Zinc 0.40 ± 0.10^ 2.83 ± 0.46 
^Significantly different from the control at P < 0.05. 
ratio of the mean cpm of stimulated cultures to that of 
unstimulated cultures) significantly at both concentrations 
of PHA and ConA. Indomethacin, on the other hand, increased 
the SI which is in agreement with the inhibitory effect of 
PG on T-cell response to mitogens. The effect of PUFA was 
not significantly different from that of the controls. 
Table 17: The effect of zinc deficiency and prostaglandin modifiers on 
blastogenic response of peripheral blood to PHA and ConA 
(mean ± SEM, n=6 per treatment) 
PHA^ ConA^ 
Treatment 5 yg/ml 10 pg/ml 5 yg/ml lO yg/ml 
Control 34. 00 + 10.89 60. 25 ± 23. 10 72. 00 ± 29 .27 51 .25 ± 18 .81 
PUFA 24. 27 ± 15.99 102. 63 + 73. 92 150. 58 ±106 .26 133 .33±102 .33 
Indo. 67. 00 ± 45.19 258. 00 ± 87. 10^ 297. 25 ±146 .43^ 251 .50±131 .38 
-Zinc 2. OQ ± 0.57^ 7. 40 ± 5. 07^ 3. 40 ± 1 .32^ 2 .80 ± 1 .22 
^Stimulation index ± standard error of a mean. 
2 Significantly different from control at P<0.025. 
3 Significantly different from control at P<0.05. 
^Significantly different from control at P<0.1. 
^Significantly different from control at P<0.01. 
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DISCUSSION 
The Effect of PG Synthesis Inhibition on Zinc Status 
Aspirin and indomethacin both decreased PG synthesis in 
all tissues studied. For most PG the inhibition was more 
than 50%. Increasing safflower oil from 1.2 to 21.2% did 
not change the PG concentration in any tissue in this experi­
ment. This is in contrast to some previous studies (118, 
119). The observed discrepancy might be explained by the 
difference in the feeding state of the rats. Mathias and 
Sullivan (personal communication, Department of Food Science 
and Nutrition, Colorado State University) showed that serum PG 
levels were higher in fasted rats than in fed rats but the 
PG concentrations in serum of fasted rats did not reflect 
differences in dietary linoleate. In addition, beef tallow 
with 0.4% calories as linoleate caused the biggest rist in 
serum PGE^, Eg, and TxBg compared to higher-percentage-
linoleate rats. In the presently reported experiment, the 
rats were fasted for four hours prior to necropsy which may 
explain why PG level did not show a change with increased 
linoleate in the diet. 
Zinc deficiency in Experiments II and III decreased the 
food intake and weight gain of rats. Doses of indomethacin 
and aspirin that caused more than 50% inhibition of PG 
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synthesis, however, did not affect normal food intakes and 
weight gains of the rats. Whereas zinc deficient animals 
were less active than normal and lost hair, the rats fed 
indomethacin and aspirin were active and healthy; no 
difference in general appearance could be detected between 
them and the control animals. Zinc deficient animals had 
lower plasma and tibia zinc concentrations than the control 
and zinc deficient pair fed animals. No difference could be 
detected between plasma and tibia zinc concentrations of 
indomethacin and aspirin fed animals and that of control 
animals. Indomethacin and aspirin slightly decreased zinc 
concentrations in gut mucosa. The decrease was not, however, 
statistically significant. 
Serum alkaline phosphatase activity was reduced by 
zinc deficiency. Indomethacin and aspirin did not have any 
effect on serum alkaline phosphatase activity. In addition, 
zinc deficiency and indomethacin had the opposite effect with 
regard to the blastogenic response of peripheral blood lympho­
cytes to mitogens. 
Song and Adham (22) showed that addition of 200 yg PGEg 
to the mucosal medium of everted jejunal sacs increased 
transport of ^^Zn while decreased its transport. The 
opposite effect was seen by addition of these PG to the sero­
sal medium. They also showed that administration of 100 ]jg 
PGEg , with ^^Zn three hours before the animals were sacri­
ficed caused an increase in zinc content of liver and pancreas. 
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Furthermore, oral administration of almost 10 mg/kg BW of 
indomethacin caused decreased liver zinc. The authors there­
fore suggested that PGE2 and act as physiological 
regulators of intestinal zinc transport. We can not reach 
the same conclusion from our study because inhibition of PG 
synthesis more than 50% with two different PG inhibitors 
did not change the zinc status of the rats as measured by 
general appearance, weight gain, tissue zinc concentration, 
alkaline phosphatase activity, and immune response. 
The dose of indomethacin used by Song and Adham (10 mg/kg 
BW) is a high dose. In our first experiment, rats receiving 
5 mg/kg BW/day of indomethacin died within 8 days with 
severe peritonitis. Indomethacin, and for that matter aspirin, 
interfere with biological functions other than PG synthesis. 
It is worth noting that the dose required for PG inhibition 
is lower than that needed for other inhibitory functions 
(120). In addition, the total amount of PG in the gut 
contents measured by radioimmunoassay in this experiment was 
63.38 ng for PGEg, 115.16 ng for PGFg^, 10.77 ng for PGE^, 
and 57.00 ng for PGIg- The dose of PG administered in the 
study by Song and Adham (22) is 200 jjg, almost 1000 times what 
is found under normal conditions in the gut contents. It will 
be very interesting to see whether similar results to those 
of Song and Adham can be obtained using more physiological 
doses of PG and their synthesis inhibitors. 
Smith et al. (89) showed that in isolated vascularly 
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perfused rat intestine direct infusion of 5 yM PGE2 (about 
1500 ug PGEg) into the lumen decreased both the cell uptake 
and plasma transfer phases of zinc absorption. In the same 
system luminal infusion of 150 mg/kg BW of aspirin did not 
affect the mucosal uptake of ^^Zn but decreased the trans-
fi S fer of Zn from mucosa to the vascular supply. Sobocinski 
et al. (79) showed that subcutaneous injection of 10 mg/kg 
BW of indomethacin in fed rats increased zinc absorption. 
The authors attributed this effect to drug induced entero­
pathy. The doses of PG and indomethacin used by these 
investigators are also unphysiological; nevertheless, they 
emphasize the point that results obtained under unphysiolo­
gical conditions should be interpreted with caution. The 
high doses might effect other cellular functions which 
indirectly influence zinc absorption. Song and Adham (22) 
in the above mentioned study showed that whereas adminis­
tration of 200 pg PGE2 increased zinc absorption, admin­
istration of 400 yg PGEg did not affect histidine absorp­
tion which was used as a control molecule. The authors con­
cluded, therefore, that the effect of PGE2 on zinc absorp­
tion is specific. It is not clear why 400 yg PGE2 rather 
than 200 yg PGE2 was used for histidine absorption. Further­
more, the effect of indomethacin on histidine absorption was 
not shown. It is also possible that the percent inhibition 
achieved in my experiment was not enough to show a deleterious 
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effect on zinc status. If PG are involved in zinc absorption, 
however, one would expect to see at least some effect by 
50% inhibition of their synthesis. 
The Effect of Zinc Deficiency on PG Synthesis 
Horrobin and Cunnane (17) suggested that zinc is required 
for the activity of the delta-6-desaturase enzyme that converts 
linoleic acid to C18:3n-6; and for the mobilization of dihomo-
y-linoleic acid (C20:3n-6) which implies that zinc is needed 
for the generation of the one series of PG. Bettger et al. 
(11) suggested that zinc deficiency accentuates the signs of 
EFA deficiency and speculated that zinc is involved in the 
metabolism of arachidonic acid, perhaps decreasing its 
degradation. It has also been speculated (12) that the 
manifestation of zinc deficiency in AE patients is due to 
its effect on PG synthesis. O'Dell et al. (16) showed that 
toxic doses of aspirin produced pathological signs similar to 
those of zinc deficiency and therefore suggested that zinc 
deficiency might interfere with the production of PG. 
Prostaglandins were not measured in any of the above 
mentioned studies and speculations were made based on indirect 
evidence. In addition, in the study by Horrobin and Cunnane 
(17) zinc deficient rats were injected with evening primrose 
oil (EPO) subcutaneously and noticed that the general condition 
of the rats and skin lesions improved but were not fully 
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recovered. They attributed the beneficial effect of EPO 
over safflower oil to its content of C18:3n-6 (precursor 
for PGE^ synthesis). These investigators concluded 
therefore that the manifestations of zinc deficiency might 
be partly due to inhibition of PGE^ synthesis and that PGE^ 
synthesis is impaired in zinc deficiency. They did not 
look, however, at the effect of EPO injection on rats 
receiving zinc adequate diet but pair fed to zinc deficient 
animals. 
It is possible that EPO will have similar beneficial 
effects over safflower oil in calorie restricted rats, i.e. 
the defect seen in enzyme delta-6-desaturase might be due 
to other factors than zinc deficiency. 
The present study shows that in most organs studied 
and for most PG measured food restriction is as effective 
in reducing PG levels as zinc deficiency. There were, of 
course, some exceptions. For example, in the gut contents 
zinc deficiency was effective in reducing PGE^, PGF2g, and 
PGIg levels. The difference was not significant by the 
Duncan multiple range test, but it was significant using 
the Student's t-test at the P<0.05 level of probability. 
Zinc deficiency increased 13,14 dihydro 15 keto-
prostaglandin ^2^ (met in serum and in 10 minute 
incubated lung homogenates. An increase in met Fg^ means 
that the PG was being catabolized faster and therefore, 
at any specific time less PG might be available to perform 
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normal biological functions. When there is an increase in 
met F2^ one might expect to see a decrease in PGFg^ level. 
Although the level of PGF2^ did not decrease significantly 
in serum and lung homogenates, it is not contradictory to 
an increase in met ^2^, the reason being that in tissue 
incubation one is looking at the synthetic ability of the 
tissue and not the absolute level of PG. Therefore, 
although the synthetic ability of PG was not changed the 
PG was being degraded faster. The change in met F2^ sug­
gests that zinc might be involved in control of PG level 
by changing its degradation rate. 
Zinc, PG, and Immune Response 
Zinc deficiency decreased the thymus weight. When the 
thymus weight to body weight ratio is considered, however, 
there was no difference between zinc deficient and control 
animals. Indomethacin did not cause any change in thymus 
weight. 
The results of this study show that zinc and PG have 
opposite effects on blastogenic response of peripheral 
blood to T-cell mitogens. Rats with zinc deficiency had a 
decrease in the stimulation index, whereas those with PG 
deficiency (in rats treated with indomethacin) had an in­
crease. PUFA did not change the stimulation index which 
is not surprising, considering that PG production was not 
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changed by PUFA in this study. This finding is important in 
interpreting the results of studies in which EFA is used as 
a PG modifier. An effect seen by EFA on immune response or 
any other physiological function can not be attributed pre­
cisely to PG unless they are measured in the system used. 
This might also explain the controversy surrounding the role 
of EFA in immune response (113). 
To my knowledge this study is the first investigation 
on the effect of long term administration of low doses of in-
domethacin on the blastogenic response of lymphocytes. The 
results indicate that with administration of 2 mg/kg BW of 
indomethacin there is a three fold increase in the stimula­
tion index. These results can have important implications in 
the management of patients who are under indomethacin treat­
ment for long periods of time such as rheumatoid arthritic 
patients. Because of the pro-inflammatory role of PG, drugs 
that inhibit their synthesis such as aspirin and indomethacin 
are used in treatment of rheumatoid arthritis (RA). Produc­
tion of IgG by the synovial B-cells and the subsequent forma­
tion of immunocomplexes is involved in the manifestation of 
RA (120). Antibody production by B-cells is controlled by T-
cells. Indomethacin therefore might be beneficial in treat­
ment of RA by control of antibody production in addition to 
the control of inflammation. Further investigations on the 
mechanism of therapeutic effect of indomethacin in RA might 
help in better understanding of the etiology of RA. 
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SUMMARY 
Experiments were conducted to investigate the role of 
prostaglandins (PG) in zinc absorption and biological functions 
(food intake and weight gain, alkaline phosphatase activity, 
T-cell-mediated immune response) and the role of zinc in PG 
Synthesis, PG levels were modified by either changing their 
precursors (essential fatty acids) concentration in the diet 
or administering an inhibitor of their synthesis, aspirin or 
indomethacin. Zinc level was modified by controlling the 
dietary concentration. 
Male weanling rats were assigned randomly to one of the 
following groups : 
Group A - (control) was fed a semi-purified diet adequate in 
zinc with composition similar to that of the average American 
diet. This diet contained 20% by weight of beef tallow and 
1.2% by weight of safflower oil. 
Group B - (PUFA) was fed the control diet except that 21.2% 
by weight of diet was composed of safflower oil (polyunsatu­
rated fat - PG precursors. 
Group G - (-Zinc) was fed a zinc deficient diet which is the 
control diet without supplementation of zinc. The level of 
zinc in this diet was less than 1 ppm. 
Group D - (Indo.) was fed the control diet with the exception 
that 2 mg/kg body weight/day of indomethacin was added to 
the diet. 
Group E - (Asp.) similar to group D except that 50 mg/kg 
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body weight/day of aspirin was added to the diet. 
Group F - (-Zinc PF) was pair fed to the zinc deficient 
group with the control diet. 
Group G - (Indo. PG) was pair fed to the indomethacin 
treated group with the control diet. 
The rats were fed the assigned diets for one month after 
which they were anesthetized with ether. Samples from blood, 
gut contents and mucosa, liver, lung, and tibia were collect­
ed for zinc, PG, and alkaline phosphatase measurements. 
In another experiment weanling rats were fed one of the 
following diets; 1) control diet, 2) PUFA diet, 3) -Zinc 
diet, 4) Indo. diet for one month. The rats were then 
anesthetized with ether and blood was collected for assay of 
PG and zinc concentrations and for lymphocyte stimulations 
with T-cell mitogen assays. 
The zinc deficient rats were less active, and had de­
creased food intake, weight gain, organ weight, plasma and 
tibia zinc concentrations and blastogenic response of 
lymphocytes to T-cell mitogens. There was no difference in 
food intake, weight gain and organ weights of rats treated 
with aspirin, indomethacin, or PUFA from that of control 
rats. Indomethacin, aspirin, and PUFA did not significantly 
change zinc concentrations in any of the tissues measured. 
Indomethacin and aspirin slightly decreased, and PUFA in­
creased zinc concentration in the mucosa. The decrease. 
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however, did not reach statistical significant. Alkaline 
phosphatase activity was not altered by PG, indomethacin, 
aspirin, or PUFA. Indomethacin increased the blastogenic 
response of peripheral blood lymphocytes to T-cell mitogens. 
There was more than 50% inhibition of PG synthesis by indo­
methacin and aspirin. This inhibition of PG synthesis, how­
ever, did not affect the zinc status of the rats as measured 
by general appearance, food intake, weight gain, organ 
weight, zinc concentration in different organs, serum alka­
line phosphatase activity, and cell mediated immune response 
to T-cell mitogens. Safflower oil did not affect either PG 
level or zinc status of the rats. 
In most organs studied and for most PG measured both 
zinc deficiency and food restriction decreased PG level to 
the same extent. Zinc deficiency seemed to be more effec­
tive in reducing PGE^, and PGI2 level in the gut con­
tents than food restriction alone. The interesting obser­
vation was that zinc deficiency increased metabolite of 
PGF2Q in serum and incubated lung homogenates, significantly. 
This rise in metabolite of PGF2g was associated with a slight 
decrease in PGF2g in serum and incubated lung homogenates. 
Lung is an important organ for degradation of prostaglandins. 
It is proposed that zinc might be involved in controlling 
tissue level of PG by changing their degradation rate. 
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